{"<Efficacy>":{"Diarrhea":{"mstID":8,"Point-of use filtered water":{"mstID":40,"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","1-6 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"6-12 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"12-23 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"24-59 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692}},"Piped water":{"mstID":41,"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","1-6 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"6-12 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"12-23 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"24-59 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101}},"Basic sanitation":{"mstID":42,"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","1-6 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"6-12 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"12-23 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"24-59 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978}},"Hand washing with soap":{"mstID":43,"source":"Efficacy source: Fischer Walker et al., publication forthcoming","1-6 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"6-12 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"12-23 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"24-59 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939}},"Hygienic disposal of stools":{"mstID":44,"source":"Efficacy source: Clasen TF, Bostoen K, Schmidt W-P, Boisson S, Fung ICH, Jenkins MW, et al. Interventions to improve disposal of human excreta for preventing diarrhoea. Cochrane Database of Systematic Reviews 2010;(5):CD007180. doi:10.1002\/14651858.CD007180.pub2","1-6 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":1,"Min":0,"Max":0}},"Neonatal Vitamin A supplementation":{"mstID":540,"1-6 months":{"Eff":0.13,"Min":-0.5384615384615385,"Max":0.5384615384615385,"alpha":9.233033,"beta":62.413497}},"Vitamin A for prevention- Two doses":{"mstID":46,"source":"Efficacy source: Imdad A, Yakoob MY, Sudfeld CR, et al. Impact of vitamin A supplementation on infant and childhood mortality. BMC Public Health 2011; 11(Suppl 3): S20. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501438. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. https:\/\/doi.org\/10.1016\/S0140-6736(13)60937-X\n\nAffected fraction: % of children that are vitamin A deficient. Source: Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746772","6-12 months":{"Eff":0.53,"Min":-0.3207547169811321,"Max":0.24528301886792453,"alpha":21.07357,"beta":19.20593},"12-23 months":{"Eff":0.53,"Min":-0.3207547169811321,"Max":0.24528301886792453,"alpha":21.07357,"beta":19.20593},"24-59 months":{"Eff":0.53,"Min":-0.3207547169811321,"Max":0.24528301886792453,"alpha":21.07357,"beta":19.20593}},"Zinc for prevention":{"mstID":24,"source":"Effectivness source: Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 2011; 11(Suppl 3): S23. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501441. \n\nBlack RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. (Supplemental material, page 18-19.) http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746772\n\nAffected fraction: % of children who are zinc deficient. Source: Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: Results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One 2012; 7(11): e50568.","12-23 months":{"Eff":0.5,"Min":-1,"Max":0.46,"alpha":1.862756,"beta":2.324572},"24-59 months":{"Eff":0.5,"Min":-1,"Max":0.46,"alpha":1.862756,"beta":2.324572}},"ORS":{"mstID":27,"source":"Efficacy source: Munos M, Fischer Walker CL, Black RE. The effect of oral rehydration solution and recommended home fluids on diarrhea mortality. International Journal of Epidemiology 2010; 39(Suppl 1): i75-i87. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348131\n\nAffected fraction: % of diarrhea susceptible to treatment with ORS (88%). Source: Rahman AE, Moinuddin M, Molla M, et al. Childhood diarrhoeal deaths in seven low- and middle-income countries. Bulletin WHO 2014. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25378757","1-6 months":{"Eff":0.93,"Aff":0.88,"Min":-0.10752688172043019,"Max":0.07526881720430102,"alpha":16.902749,"beta":1.732806},"6-12 months":{"Eff":0.93,"Aff":0.88,"Min":-0.10752688172043019,"Max":0.07526881720430102,"alpha":16.902749,"beta":1.732806},"12-23 months":{"Eff":0.93,"Aff":0.88,"Min":-0.10752688172043019,"Max":0.07526881720430102,"alpha":16.902749,"beta":1.732806},"24-59 months":{"Eff":0.93,"Aff":0.88,"Min":-0.10752688172043019,"Max":0.07526881720430102,"alpha":16.902749,"beta":1.732806}},"Antibiotics for Dysentary":{"mstID":28,"source":"Efficacy source: Das JK, Ali A, Salam RA, et al. Antibiotics for the treatment of Cholera, Shigella and Cryptosporidium in children. BMC Public Health 2013; 13(Suppl 3): S10. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564492\n\nAffected fraction: % of diarrhea susceptible to treatment by antibiotics (12%). Source: Rahman AE, Moinuddin M, Molla M, et al. Childhood diarrhoeal deaths in seven low- and middle-income countries. Bulletin WHO 2014. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25378757","1-6 months":{"Eff":0.82,"Aff":0.12,"Min":-0.1829268292682926,"Max":0.20731707317073178,"alpha":1.3350327,"beta":0.6743666},"6-12 months":{"Eff":0.82,"Aff":0.12,"Min":-0.1829268292682926,"Max":0.20731707317073178,"alpha":1.3350327,"beta":0.6743666},"12-23 months":{"Eff":0.82,"Aff":0.12,"Min":-0.1829268292682926,"Max":0.20731707317073178,"alpha":1.3350327,"beta":0.6743666},"24-59 months":{"Eff":0.82,"Aff":0.12,"Min":-0.1829268292682926,"Max":0.20731707317073178,"alpha":1.3350327,"beta":0.6743666}},"Zinc for treatment":{"mstID":29,"source":"Efficacy source: Fischer Walker CL, Black RE. Zinc for the treatment of diarrhea: Effect on diarrhea morbidity, mortality and incidence of future episodes. International Journal of Epidemiology 2010; 39(Suppl 1): i63-i69. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348128","1-6 months":{"Eff":0.23,"Aff":1,"Min":-0.3478260869565218,"Max":0.3478260869565217,"alpha":22.86783,"beta":77.06087},"6-12 months":{"Eff":0.23,"Aff":1,"Min":-0.3478260869565218,"Max":0.3478260869565217,"alpha":22.86783,"beta":77.06087},"12-23 months":{"Eff":0.23,"Aff":1,"Min":-0.3478260869565218,"Max":0.3478260869565217,"alpha":22.86783,"beta":77.06087},"24-59 months":{"Eff":0.23,"Aff":1,"Min":-0.3478260869565218,"Max":0.3478260869565217,"alpha":22.86783,"beta":77.06087}}},"Pneumonia":{"mstID":9,"Zinc for prevention":{"mstID":24,"source":"Efficacy source: Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 2011; 11(Suppl 3): S23. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501441. \n\nBlack RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. (Supplemental material, page 18-19.) http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746772\n\nAffected fraction: % of children who are zinc deficient. Source: Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: Results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One 2012; 7(11): e50568.","1-6 months":{"alpha":45.78344,"beta":44.4524},"6-12 months":{"alpha":45.78344,"beta":44.4524},"12-23 months":{"Eff":0.49,"Min":-1,"Max":0.6326530612244899,"alpha":45.78344,"beta":44.4524},"24-59 months":{"Eff":0.49,"Min":-1,"Max":0.6326530612244899,"alpha":45.78344,"beta":44.4524}},"Case management of pneumonia (oral antibiotics)":{"mstID":30,"source":"Efficacy source: Theodoratou E, Al-Jilaihawi S, Woodward F, et al. The effect of case management on childhood pneumonia mortality in developing countries. International Journal of Epidemiology 2010; 39(Suppl 1): i155-i171. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348118","1-6 months":{"Eff":0.7,"Aff":1,"Min":-0.14285714285714282,"Max":0.142857142857143,"alpha":50.63575,"beta":22.14568},"6-12 months":{"Eff":0.7,"Aff":1,"Min":-0.14285714285714282,"Max":0.142857142857143,"alpha":50.63575,"beta":22.14568},"12-23 months":{"Eff":0.7,"Aff":1,"Min":-0.14285714285714282,"Max":0.142857142857143,"alpha":50.63575,"beta":22.14568},"24-59 months":{"Eff":0.7,"Aff":1,"Min":-0.14285714285714282,"Max":0.142857142857143,"alpha":50.63575,"beta":22.14568}},"Oxygen and pulse oximetry for pneumonia":{"mstID":528,"source":"Efficacy source: TBD","1-6 months":{"Eff":0.58,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":0.58,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":0.58,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":0.58,"Aff":1,"Min":0,"Max":0}}},"Measles":{"mstID":10,"Vitamin A for treatment":{"mstID":31,"source":"Efficacy source: Sudfeld CR, Navar AM, Halsey NA. Efficacy of measles vaccination and vitamin A treatment. International Journal of Epidemiology 2010; 39(Suppl 1): i48-i55. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348126","1-6 months":{"Eff":0.62,"Aff":1,"Min":-0.6935483870967741,"Max":0.32258064516129026,"alpha":3.620798,"beta":2.693281},"6-12 months":{"Eff":0.62,"Aff":1,"Min":-0.6935483870967741,"Max":0.32258064516129026,"alpha":3.620798,"beta":2.693281},"12-23 months":{"Eff":0.62,"Aff":1,"Min":-0.6935483870967741,"Max":0.32258064516129026,"alpha":3.620798,"beta":2.693281},"24-59 months":{"Eff":0.62,"Aff":1,"Min":-0.6935483870967741,"Max":0.32258064516129026,"alpha":3.620798,"beta":2.693281}}},"Malaria":{"mstID":11,"ITN\/IRS":{"mstID":22,"source":"Efficacy source: Eisele TP, Larsen D, Steketee RW. Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. International Journal of Epidemiology 2010; 39(Suppl 1): i88-i101.","1-6 months":{"Eff":0.55,"Aff":1,"Min":-0.10909090909090918,"Max":0.10909090909090897,"alpha":142.6235,"beta":117.1569},"6-12 months":{"Eff":0.55,"Aff":1,"Min":-0.10909090909090918,"Max":0.10909090909090897,"alpha":142.6235,"beta":117.1569},"12-23 months":{"Eff":0.55,"Aff":1,"Min":-0.10909090909090918,"Max":0.10909090909090897,"alpha":142.6235,"beta":117.1569},"24-59 months":{"Eff":0.55,"Aff":1,"Min":-0.10909090909090918,"Max":0.10909090909090897,"alpha":142.6235,"beta":117.1569}},"Antimalarials - ACT":{"mstID":32,"source":"Efficacy source: Thwing J, Eisele TP, Steketee RW. Protective efficacy of malaria case management for preventing malaria mortality in children: A systematic review for the Lives Saved Tool. BMC Public Health 2011; 11(Suppl 3): S14. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501431","1-6 months":{"Eff":0.99,"Aff":1,"Min":-0.05050505050505055,"Max":0.01010101010101011,"alpha":56.367645,"beta":1.004669},"6-12 months":{"Eff":0.99,"Aff":1,"Min":-0.05050505050505055,"Max":0.01010101010101011,"alpha":56.367645,"beta":1.004669},"12-23 months":{"Eff":0.99,"Aff":1,"Min":-0.05050505050505055,"Max":0.01010101010101011,"alpha":57.17853,"beta":2.250607},"24-59 months":{"Eff":0.97,"Aff":1,"Min":-0.11340206185567009,"Max":0.020618556701030948,"alpha":58.024905,"beta":2.270641}}},"Neonatal Diarrhea":{"mstID":1,"Point-of use filtered water":{"mstID":40,"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","0-1 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692}},"Piped water":{"mstID":41,"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","0-1 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101}},"Basic sanitation":{"mstID":42,"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","0-1 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978}},"Hand washing with soap":{"mstID":43,"source":"Efficacy source: Fischer Walker et al., publication forthcoming","0-1 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939}},"Hygienic disposal of stools":{"mstID":44,"source":"Efficacy source: Clasen TF, Bostoen K, Schmidt W-P, Boisson S, Fung ICH, Jenkins MW, et al. Interventions to improve disposal of human excreta for preventing diarrhoea. Cochrane Database of Systematic Reviews 2010;(5):CD007180. doi:10.1002\/14651858.CD007180.pub2","0-1 months":{"Eff":0,"Aff":1,"Min":0,"Max":0}},"ORS":{"mstID":27,"source":"Efficacy source: Munos M, Fischer Walker CL, Black RE. The effect of oral rehydration solution and recommended home fluids on diarrhea mortality. International Journal of Epidemiology 2010; 39(Suppl 1): i75-i87. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348131\n\nAffected fraction: % of diarrhea susceptible to treatment with ORS (88%). Source: Rahman AE, Moinuddin M, Molla M, et al. Childhood diarrhoeal deaths in seven low- and middle-income countries. Bulletin WHO 2014. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25378757","0-1 months":{"Eff":0.93,"Aff":0.88,"Min":-0.10752688172043019,"Max":0.07526881720430102,"alpha":11.725297,"beta":1.332209}},"Antibiotics for Dysentary":{"mstID":28,"source":"Efficacy source: Das JK Ali A, Salam RA, et al. Antibiotics for the treatment of Cholera, Shigella and Cryptosporidium in children. BMC Public Health 2013; 13(Suppl 3): S10. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564492\n\nAffected fraction: % of diarrhea susceptible to treatment by antibiotics (12%). Source: Rahman AE, Moinuddin M, Molla M, et al. Childhood diarrhoeal deaths in seven low- and middle-income countries. Bulletin WHO 2014. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25378757","0-1 months":{"Eff":0.82,"Aff":0.12,"Min":-0.1829268292682926,"Max":0.20731707317073178,"alpha":1.3350327,"beta":0.6743666}},"Zinc for treatment":{"mstID":29,"source":"Efficacy source: Fischer Walker CL, Black RE. Zinc for the treatment of diarrhea: Effect on diarrhea morbidity, mortality and incidence of future episodes. International Journal of Epidemiology 2010; 39(Suppl 1): i63-i69. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348128","0-1 months":{"Eff":0.23,"Aff":1,"Min":-0.3478260869565218,"Max":0.3478260869565217,"alpha":22.86783,"beta":77.06087}},"Neonatal Vitamin A supplementation":{"mstID":540,"0-1 months":{"Eff":0.13,"Min":-0.5384615384615385,"Max":0.5384615384615385,"alpha":9.233033,"beta":62.413497}}},"Neonatal Asphyxia":{"mstID":3,"Neonatal resuscitation":{"mstID":15,"source":"Efficacy source: Lee AC, Cousens S, Mullany LC, et al. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: A systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S12. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501429","0-1 months":{"Eff":0.3,"Aff":1,"Min":-0.4666666666666666,"Max":0.36666666666666664,"alpha":14.09571,"beta":33.37264}},"Immediate drying and additional stimulation":{"mstID":174,"source":"Efficacy source: Lee AC, Cousens S, Mullany LC, et al. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: A systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S12. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501429","0-1 months":{"Eff":0.1,"Aff":1,"Min":-0.5,"Max":0,"alpha":56.80693,"beta":511.79828}},"Assisted vaginal delivery":{"mstID":506,"source":"Efficacy source: Lee AC, Cousens S, Darmstadt GL, et al. Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3):S10. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501427","0-1 months":{"Eff":0.4,"Aff":1,"Min":0,"Max":0.3125,"alpha":73.69084,"beta":111.04873}},"Cesarean delivery":{"mstID":509,"source":"Efficacy source: Lee AC, Cousens S, Darmstadt GL, et al. Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3):S10. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501427","0-1 months":{"Eff":0.45,"Aff":1,"Min":-0.2222222222222223,"Max":0.2222222222222223,"alpha":40.10853,"beta":49.49555}},"Newborn referral and transportation":{"mstID":664,"0-1 months":{"Eff":0.24,"Aff":1,"Min":-0.5,"Max":0.4166666666666668}},"Magnesium Sulfate for neuroprotection in asphyxiated infants":{"mstID":671,"0-1 months":{"Eff":0.17,"Aff":0.1,"Min":-0.9411764705882353,"Max":0.8235294117647057}}},"Neonatal Prematurity":{"mstID":4,"Antenatal corticosteroids for preterm labor":{"mstID":5,"source":"McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020 Dec 25;12(12):CD004454. doi: 10.1002\/14651858.CD004454.pub4. PMID: 33368142; PMCID: PMC8094626","0-1 months":{"Eff":0.15,"Aff":1,"Min":0,"Max":0}},"Antibiotics for preterm or prolonged PROM":{"mstID":6,"source":"Efficacy source: Cousens S, Blencowe H, Gravett M, et al. Antibiotics for pre-term pre-labour rupture of the membranes: Prevention of neonatal deaths due to complications of preterm birth and infection. International Journal of Epidemiology 2010; 39(Suppl 1): i34-i43. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348116\n\nAffected fraction: % of neonatal sepsis susceptible to treatment with antibiotics for pPRoM (19.8%).","0-1 months":{"Eff":0.12,"Aff":0.33,"Min":-0.75,"Max":0.6666666666666669,"alpha":4.222635,"beta":31.521783}},"Neonatal resuscitation":{"mstID":15,"source":"Efficacy source: Lee AC, Cousens S, Mullany LC, et al. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: A systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S12. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501429","0-1 months":{"Eff":0.1,"Aff":1,"Min":0,"Max":1,"alpha":10.51354,"beta":95.00225}},"Kangaroo mother care":{"mstID":16,"source":"Efficacy source: Lawn JE, Mwansa-Kambafwile J, Horta BL, et al. 'Kangaroo Mother Care' to prevent deaths due to preterm birth complications. International Journal of Epidemiology 2010; 39(Suppl 1): i44-i54. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348117\n\nAffected fraction: % of premature births that survive to day 3 (58%)","0-1 months":{"Eff":0.51,"Aff":0.357,"Min":-0.6470588235294118,"Max":0.3921568627450979,"alpha":4.653665,"beta":4.959702}},"Full supportive care for prematurity":{"mstID":322,"source":"Efficacy source: Bhutta ZA, Das JK, Bahl R, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet 2014; 384(9940): 347-70. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24853604","0-1 months":{"Eff":0.71,"Aff":0.96,"Min":-0.15492957746478872,"Max":0.267605633802817,"alpha":38.16697,"beta":10.04957}},"iKMC":{"mstID":547,"0-1 months":{"Eff":0.873,"Aff":0.96,"Min":-0.3127147766323024,"Max":0.03092783505154642}},"Thermal protection":{"mstID":168,"source":"Efficacy source: Bhutta ZA, Das JK, Bahl R, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet 2014; 384(9940): 347-70. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24853604","0-1 months":{"Eff":0.2,"Aff":1,"Min":-0.25000000000000006,"Max":0.24999999999999994,"alpha":47.3222,"beta":189.6618}},"Immediate drying and additional stimulation":{"mstID":174,"source":"Efficacy source: Lee AC, Cousens S, Mullany LC, et al. Neonatal resuscitation and immediate newborn assessment and stimulation for the prevention of neonatal deaths: A systematic review, meta-analysis and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S12. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501429","0-1 months":{"Eff":0.1,"Aff":1,"Min":-0.5,"Max":0,"alpha":57.2802,"beta":515.6974}},"Antibiotics for maternal sepsis":{"mstID":505,"source":"Efficacy source: Cousens S, Blencowe H, Gravett M, et al. Antibiotics for pre-term pre-labour rupture of the membranes: Prevention of neonatal deaths due to complications of preterm birth and infection. International Journal of Epidemiology 2010; 39(Suppl 1): i34-i43. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348116\n\nAffected fraction: % of neonatal sepsis susceptible to treatment with antibiotics for pPRoM (19.8%).","0-1 months":{"Eff":0,"Aff":1,"Min":0,"Max":0,"alpha":4.222635,"beta":31.521783}},"Cesarean delivery":{"mstID":509,"source":"Efficacy source: Lee AC, Cousens S, Darmstadt GL, et al. Care during labor and birth for the prevention of intrapartum-related neonatal deaths: a systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3):S10. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501427"},"Delayed cord clamping":{"mstID":535,"source":"Efficacy source: Rabe H, Gyte GML, D\u00edaz-Rossello JL, Duley L. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD003248. DOI: 10.1002\/14651858.CD003248.pub4.","0-1 months":{"Eff":0.27,"Aff":1,"Min":-0.9259259259259259,"Max":0.7037037037037037}},"iKMC community":{"mstID":659,"0-1 months":{"Eff":0.22,"Aff":0.277,"Min":-0.6363636363636364,"Max":0.5454545454545455}},"iKMC facility":{"mstID":660,"0-1 months":{"Eff":0.22,"Aff":0.723,"Min":-0.6363636363636364,"Max":0.5454545454545455}},"nCPAP":{"mstID":661,"0-1 months":{"Eff":0.47,"Aff":1,"Min":-0.6382978723404255,"Max":0.4042553191489363}},"Newborn referral and transportation":{"mstID":664,"0-1 months":{"Eff":0.24,"Aff":1,"Min":-0.5,"Max":0.4166666666666668}},"Animal-derived surfactant":{"mstID":665,"0-1 months":{"Eff":0.32,"Aff":1,"Min":-0.43750000000000006,"Max":0.34374999999999994}},"Prophylactic antifungals":{"mstID":666,"0-1 months":{"Eff":0.22,"Aff":0.05,"Min":-0.9545454545454546,"Max":0.7272727272727273}}},"Neonatal Sepsis":{"mstID":17,"Syphilis detection and treatment":{"mstID":1,"source":"Efficacy source: Blencowe H, Cousens S, Kamb M, et al. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health 2011; 11(Suppl 3): S9. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501460\n\nAffected fraction: % of neonatal sepsis due to syphilis. Source: Newman L et al., \"Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting,\" PLOS One 2015. (Regional values for year 2012) https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26646541","0-1 months":{"Eff":0.97,"Aff":0.03,"Min":-0.04123711340206178,"Max":0.010309278350515474,"alpha":294.761527,"beta":9.613794}},"Clean birth environment":{"mstID":11,"source":"Efficacy source: Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: A systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S11. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3231884\/","0-1 months":{"Eff":0.27,"Aff":1,"Min":-0.12037037037037047,"Max":0.34259259259259245,"alpha":50.95681,"beta":138.2072}},"Antibiotics for preterm or prolonged PROM":{"mstID":6,"source":"Efficacy source: Cousens S, Blencowe H, Gravett M, et al. Antibiotics for pre-term pre-labour rupture of the membranes: Prevention of neonatal deaths due to complications of preterm birth and infection. International Journal of Epidemiology 2010; 39(Suppl 1): i34-i43. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348116\n\nAffected fraction: % of neonatal sepsis susceptible to treatment with antibiotics for pPRoM (19.8%).","0-1 months":{"Eff":0.39,"Aff":0.198,"Min":-0.41025641025641024,"Max":0.3333333333333333,"alpha":15.52927,"beta":24.78044}},"Full supportive care for severe infection in neonates":{"mstID":13,"source":"Efficacy source: Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11(Suppl 3): S13. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501430","0-1 months":{"Eff":0.8,"Aff":1,"Min":-0.06250000000000006,"Max":0.06249999999999992,"alpha":185.9367,"beta":47.0268}},"Oral antibiotic case management of severe infection in neonates":{"mstID":69,"source":"Efficacy source: Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11(Suppl 3): S13. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501430","0-1 months":{"Eff":0.28,"Aff":1,"Min":-0.28571428571428575,"Max":0.294642857142857,"alpha":30.83708,"beta":79.82654}},"Injectable antibiotic case management of severe infection in neonates":{"mstID":70,"source":"Efficacy source: Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11(Suppl 3): S13. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501430","0-1 months":{"Eff":0.65,"Aff":1,"Min":-0.23076923076923078,"Max":0.07692307692307682,"alpha":69.07682,"beta":37.67387}},"Thermal protection":{"mstID":168,"source":"Efficacy source: Bhutta ZA, Das JK, Bahl R, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet 2014; 384(9940): 347-70. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24853604","0-1 months":{"Eff":0.1,"Aff":1,"Min":-0.20000000000000004,"Max":0.7,"alpha":14.46764,"beta":130.6995}},"Clean cord care":{"mstID":255,"source":"Efficacy source: Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: A systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S11. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3231884\/","0-1 months":{"Eff":0.4,"Aff":1,"Min":-0.37500000000000006,"Max":0.24999999999999994,"alpha":23.30808,"beta":35.40865}},"Antibiotics for maternal sepsis":{"mstID":505,"source":"Efficacy source: Cousens S, Blencowe H, Gravett M, et al. Antibiotics for pre-term pre-labour rupture of the membranes: Prevention of neonatal deaths due to complications of preterm birth and infection. International Journal of Epidemiology 2010; 39(Suppl 1): i34-i43. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348116\n\nAffected fraction: % of neonatal sepsis susceptible to treatment with antibiotics for pPRoM (19.8%).","0-1 months":{"Eff":0,"Aff":1,"Min":0,"Max":0,"alpha":15.31195,"beta":24.45812}},"Oral antibiotics":{"mstID":662,"0-1 months":{"Eff":0.25,"Aff":0.277,"Min":-0.28,"Max":0.24}},"Injectable antibiotics secondary":{"mstID":663,"0-1 months":{"Eff":0.8,"Aff":0.578,"Min":0,"Max":0}},"Injectable antibiotics tertiary facility":{"mstID":667,"0-1 months":{"Eff":0.9,"Aff":0.145,"Min":0,"Max":0}},"Antibiotic stewardship and education":{"mstID":668,"0-1 months":{"Eff":0.32,"Aff":1,"Min":-0.84375,"Max":0.59375}},"Topical emollients for preterm newborns":{"mstID":669,"0-1 months":{"Eff":0.19,"Aff":1,"Min":-0.6842105263157895,"Max":0.5789473684210525}},"Probiotics\/Synbiotics in hospitalized preterm newborns":{"mstID":670,"0-1 months":{"Eff":0.29,"Aff":1,"Min":-0.48275862068965514,"Max":0.41379310344827586}}},"Neonatal Pneumonia":{"mstID":18,"Oral antibiotic case management of severe infection in neonates":{"mstID":69,"source":"Efficacy source: Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11(Suppl 3): S13. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501430","0-1 months":{"Eff":0.42,"Aff":1,"Min":-0.5714285714285714,"Max":0.40476190476190477,"alpha":7.11587,"beta":10.31942}},"Injectable antibiotic case management of severe infection in neonates":{"mstID":70,"source":"Efficacy source: Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11(Suppl 3): S13. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501430","0-1 months":{"Eff":0.75,"Aff":1,"Min":-0.06666666666666672,"Max":0.08333333333333333,"alpha":153.9431,"beta":51.7991}},"Full supportive care for severe infection in neonates":{"mstID":13,"source":"Efficacy source: Zaidi AK, Ganatra HA, Syed S, et al. Effect of case management on neonatal mortality due to sepsis and pneumonia. BMC Public Health 2011; 11(Suppl 3): S13. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501430","0-1 months":{"Eff":0.9,"Aff":1,"Min":-0.01111111111111112,"Max":0.05555555555555548,"alpha":194.20858,"beta":22.06494}},"Oral antibiotics":{"mstID":662,"0-1 months":{"Eff":0.42,"Aff":0.277,"Min":-0.5714285714285714,"Max":0.40476190476190477}},"Injectable antibiotics secondary":{"mstID":663,"0-1 months":{"Eff":0.9,"Aff":0.578,"Min":0,"Max":0}},"Injectable antibiotics tertiary":{"mstID":667,"0-1 months":{"Eff":0.95,"Aff":0.145,"Min":0,"Max":0}},"Topical emollients for preterm newborns":{"mstID":669,"0-1 months":{"Eff":0.19,"Aff":1,"Min":-0.6842105263157895,"Max":0.5789473684210525}},"Probiotics\/Synbiotics in hospitalized preterm newborns":{"mstID":670,"0-1 months":{"Eff":0.29,"Aff":1,"Min":-0.48275862068965514,"Max":0.41379310344827586}}},"Neonatal  Tetanus":{"mstID":5,"Tetanus Toxoid":{"mstID":4,"source":"Efficacy source: Blencowe H, Lawn J, Vandelaer J, et al. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. International Journal of Epidemiology 2010; 39(Suppl 1): i102-i109. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2845866\/","0-1 months":{"Eff":0.94,"Aff":1,"Min":-0.14893617021276587,"Max":0.04255319148936174,"alpha":36.220638,"beta":2.792855}},"Clean birth environment":{"mstID":11,"source":"Efficacy source: Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: A systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S11. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3231884\/","0-1 months":{"Eff":0.38,"Aff":1,"Min":-0.1052631578947368,"Max":0.05263157894736847,"alpha":390.7281,"beta":636.1569}},"Clean cord care":{"mstID":255,"source":"Efficacy source: Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: A systematic review and Delphi estimation of mortality effect. BMC Public Health 2011; 11(Suppl 3): S11. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3231884\/","0-1 months":{"Eff":0.4,"Aff":1,"Min":-0.25000000000000006,"Max":0.24999999999999994,"alpha":34.98045,"beta":52.9655}}},"Neonatal  Congenital anomalies":{"mstID":6,"Periconceptual Folic Acid":{"mstID":7,"source":"Efficacy source: Keats EC, Neufeld LM, Garrett GS, Mbuya MNN, Bhutta ZA. Improved micronutrient status and health outcomes in low- and middle-income countries following large-scale fortification: evidence from a systematic review and meta-analysis. Am J Clin Nutr. 2019;109(6):1696-1708. doi:10.1093\/ajcn\/nqz023. https:\/\/pubmed.ncbi.nlm.nih.gov\/30997493\/\n\nAffected fraction: % of congenital anomalies due to neural tube disorders. Blencowe H, Cousens S, Modell B, et al. Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology 2010; 39(Suppl 1): i110-i121. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2845867\/","0-1 months":{"Eff":0.41,"Min":-0.26829268292682923,"Max":0.24390243902439035,"alpha":32.96859,"beta":47.92397}}}},"<Age and Birth Order>":{"<18 years - first birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":3.14,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.75,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1.52,"Aff":1,"Min":0,"Max":0}},"<18 years - second and third births":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1.6,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.4,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1.2,"Aff":1,"Min":0,"Max":0}},"<18 years - greater than third birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1.6,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.4,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1.2,"Aff":1,"Min":0,"Max":0}},"18-34 years- first birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1.73,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.75,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1.52,"Aff":1,"Min":0,"Max":0}},"18-34 years- second and third births":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1,"Aff":1,"Min":0,"Max":0}},"18-34 years- greater than third birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1,"Aff":1,"Min":0,"Max":0}},"35-49 years- first birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1.73,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.75,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1.52,"Aff":1,"Min":0,"Max":0}},"35-49 years- second and third births":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1.57,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.33,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1,"Aff":1,"Min":0,"Max":0}},"35-49 years- greater than third birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of parity and maternal age with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S2. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847520\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"RR":1.57,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"RR":1.33,"Aff":1,"Min":0,"Max":0},"Term SGA":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"<Birth Spacing>":{"First Birth":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of birth intervals with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S3. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847557\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"Eff":1,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"Eff":1,"Aff":1,"Min":0,"Max":0},"Term SGA":{"Eff":1,"Aff":1,"Min":0,"Max":0}},"<18 months":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of birth intervals with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S3. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847557\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"Eff":3.03,"Aff":1,"Min":-0.2937293729372936,"Max":0.41914191419141916,"mean":1.108563,"sd":0.1774302},"Pre-term AGA":{"Eff":1.49,"Aff":1,"Min":-0.3221476510067114,"Max":0.46308724832214776,"mean":0.3987761,"sd":0.1983842},"Term SGA":{"Eff":1.41,"Aff":1,"Min":-0.12765957446808507,"Max":0.15602836879432624,"mean":0.3435897,"sd":0.06968268}},"18 - 23 months":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of birth intervals with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S3. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847557\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"Eff":1.77,"Aff":1,"Min":-0.3220338983050848,"Max":0.48022598870056504,"mean":0.5709795,"sd":0.1982985},"Pre-term AGA":{"Eff":1.1,"Aff":1,"Min":-0.25454545454545463,"Max":0.33636363636363625,"mean":0.09531018,"sd":0.1479375},"Term SGA":{"Eff":1.18,"Aff":1,"Min":-0.12711864406779655,"Max":0.15254237288135608,"mean":0.1655144,"sd":0.0693664}},"24 months or greater":{"source":"Relative risk source: Kozuki N, Lee ACC, Silveira MF, et al. The associations of birth intervals with small-for-gestational-age, preterm, and neonatal and infant mortality: a meta-analysis. BMC Public Health 2013; 13(Suppl 3): S3. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847557\/. (Relative risks are from unpublished calculations associated with the paper.)","Pre-term SGA":{"Eff":1,"Aff":1,"Min":0,"Max":0},"Pre-term AGA":{"Eff":1,"Aff":1,"Min":0,"Max":0},"Term SGA":{"Eff":1,"Aff":1,"Min":0,"Max":0}}},"<Interventions for birth outcomes>":{"Prevention of malaria in pregnancy":{"mstID":1,"source":"Efficacy source: Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD003755. doi: 10.1002\/14651858.CD003755.pub2. PMID: 16625591; PMCID: PMC653Gamble C, Ekwaru JP, ter Kuile FO. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD003755. doi: 10.1002\/14651858.CD003755.pub2. PMID: 16625591; PMCID: PMC6532581. https:\/\/pubmed.ncbi.nlm.nih.gov\/16625591\/ (The effect size for ITN usage is used as a proxy for IPTp.) \n\nAffected fraction: % women exposed to falciparum malaria having their 1st or 2nd birth","Adjusted relative risk for Preterm":1.45,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.26,"Min":-2.192307692307692,"Max":1.2307692307692306},"Pre-term AGA":{"Eff":0.26,"Min":-2.192307692307692,"Max":1.2307692307692306}},"Balanced Energy Supplementation":{"mstID":2,"source":"Efficacy source: Lassi ZS, Padhani ZA, Rabbani A, Rind F, Salam RA, Das JK, et al. Impact of Dietary Interventions during Pregnancy on Maternal, Neonatal, and Child Outcomes in Low- and Middle-Income Countries. Nutrients. 2020;12(2).\n\nAffected fraction source: % of population who are food insecure.  Suite of Food Security Indicators  [Available from: https:\/\/www.fao.org\/faostat\/en\/#data\/FS].","Adjusted relative risk for Preterm":1,"Adjusted relative risk for SGA":1.41,"Pre-term SGA":{"Eff":0.29,"Min":-0.7931034482758621,"Max":0.5862068965517243,"alpha":3.277906,"beta":8.497248},"Term SGA":{"Eff":0.29,"Min":-0.7931034482758621,"Max":0.5862068965517243,"alpha":3.277906,"beta":8.497248}},"Iron Folate supplement":{"mstID":3,"source":"Efficacy source: Haider BA, Olofin I, Wang M, et al. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013;346:f3443. https:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0057254\/. See also: LiST Technical Note. http:\/\/livessavedtool.org\/images\/documents\/Technical_Notes\/Iron-and-MMN-effect-sizes.pdf","Pre-term SGA":{"Eff":0,"Aff":1,"Min":0,"Max":0,"alpha":1.041665,"beta":6.300814},"Pre-term AGA":{"Aff":1},"Term SGA":{"Eff":0,"Aff":1,"Min":0,"Max":0,"alpha":1.041665,"beta":6.300814}},"Multiple micronutrient supplementation":{"mstID":4,"source":"Efficacy source: Keats EC, Haider BA, Tam E, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;3:CD004905. for Preterm births\nOh C, Keats EC, Bhutta ZA. Vitamin and Mineral Supplementation During Pregnancy on Maternal, Birth, Child Health and Development Outcomes in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Nutrients. 2020;12(2). for SGA\n\nAffected fraction: all pregnant women","Adjusted relative risk for Preterm":1,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.05,"Aff":1,"Min":-1.2,"Max":1},"Pre-term AGA":{"Eff":0.05,"Aff":1,"Min":-1.2,"Max":1},"Term SGA":{"Eff":0.07,"Aff":1,"Min":-0.7142857142857143,"Max":0.7142857142857141}},"Calcium supplementation":{"mstID":6,"source":"Efficacy source: Hofmeyr GJ, Lawrie TA, Atallah AN, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018;10:CD001059.\n\nAffected fraction: % of pregnant women who are calcium deficient. Source: Beal T, Massiot E, Arsenault JE, Smith MR, Hijmans RJ. Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes. PLoS One. 2017;12(4):1\u201320. http:\/\/dx.doi.org\/10.1371\/journal.pone.0175554","Adjusted relative risk for Preterm":1.23,"Pre-term SGA":{"Eff":0.19,"Min":-1.105263157894737,"Max":0.894736842105263},"Pre-term AGA":{"Eff":0.19,"Min":-1.105263157894737,"Max":0.894736842105263}},"ITN ownership":{"mstID":7,"Pre-term SGA":{"Eff":0,"Aff":0,"Min":0,"Max":0,"alpha":0,"beta":0},"Pre-term AGA":{"Aff":1},"Term SGA":{"Eff":0,"Aff":0,"Min":0,"Max":0,"alpha":0,"beta":0}},"Treatment for Bacteriuria":{"mstID":13,"source":"Efficacy source: Wingert A, Pillay J, Sebastianski M, et al. Asymptomatic bacteriuria in pregnancy: systematic reviews of screening and treatment Efficacy and patient preferences. BMJ Open2019;9:e021347. doi:10.1136\/bmjopen-2017-021347","Adjusted relative risk for Preterm":1.77,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.43,"Aff":0.11,"Min":-2.302325581395349,"Max":0.8372093023255816},"Pre-term AGA":{"Eff":0.43,"Aff":0.11,"Min":-2.302325581395349,"Max":0.8372093023255816}},"Low dose aspirin":{"mstID":10,"Adjusted relative risk for Preterm":1.1,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.11,"Min":-0.8181818181818182,"Max":0.7272727272727273},"Pre-term AGA":{"Eff":0.11,"Min":-0.8181818181818182,"Max":0.7272727272727273}},"Progesterone for high risk pregnancy":{"mstID":11,"Adjusted relative risk for Preterm":2.28,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.08,"Min":-1,"Max":1},"Pre-term AGA":{"Eff":0.08,"Min":-1,"Max":1}},"Stop smoking education":{"mstID":12,"Adjusted relative risk for Preterm":1.22,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.07,"Min":-2.571428571428571,"Max":2.2857142857142856},"Pre-term AGA":{"Eff":0.07,"Min":-2.571428571428571,"Max":2.2857142857142856}},"Omega 3 FA supplements":{"mstID":14,"Adjusted relative risk for Preterm":1,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.1,"Aff":1,"Min":-1.1,"Max":1},"Pre-term AGA":{"Eff":0.1,"Aff":1,"Min":-1.1,"Max":1}},"Zinc supplements":{"mstID":16,"Adjusted relative risk for Preterm":1.12,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.13,"Min":-1.2307692307692308,"Max":1},"Pre-term AGA":{"Eff":0.13,"Min":-1.2307692307692308,"Max":1}},"Syphilis detection and treatment":{"mstID":17,"Adjusted relative risk for Preterm":2.8,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.51,"Min":-0.2549019607843137,"Max":0.13725490196078421},"Pre-term AGA":{"Eff":0.51,"Min":-0.2549019607843137,"Max":0.13725490196078421}},"Folic acid fortification":{"mstID":15,"Adjusted relative risk for Preterm":1.1,"Adjusted relative risk for SGA":1,"Pre-term SGA":{"Eff":0.12,"Min":-0.25,"Max":0.25},"Pre-term AGA":{"Eff":0.12,"Min":-0.25,"Max":0.25}}},"<Impacts on Stunting>":{"Impact of IUGR\/Low birth weight on stunting":{"Term AGA":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c93e9b9f4e1fc34bdbe9cc8\/1553197497868\/Birth+outcomes+on+stunting+at+1+mo.pdf","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0,"alpha":0,"beta":0}},"Term SGA":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c93e9b9f4e1fc34bdbe9cc8\/1553197497868\/Birth+outcomes+on+stunting+at+1+mo.pdf","0-1 months":{"OR":5,"Aff":1,"Min":-0.14000000000000004,"Max":0.18000000000000008,"alpha":1.609438,"beta":0.08444769}},"Preterm AGA":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c93e9b9f4e1fc34bdbe9cc8\/1553197497868\/Birth+outcomes+on+stunting+at+1+mo.pdf","0-1 months":{"OR":6.4,"Aff":1,"Min":-0.2031250000000001,"Max":0.24999999999999994,"alpha":1.856298,"beta":0.1138508}},"Preterm SGA":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c93e9b9f4e1fc34bdbe9cc8\/1553197497868\/Birth+outcomes+on+stunting+at+1+mo.pdf","0-1 months":{"OR":46.5,"Aff":1,"Min":-0.3419354838709677,"Max":0.5139784946236561,"alpha":3.839452,"beta":0.2116064}}},"Impact of previous stunting on stunting":{"Not stunted at previous age cohort":{"source":"Odds ratio source: Cousens S, Perin J, Christian P, et al. Modelling stunting in LiST: the effect of applying smoothing to linear growth data. BMC Public Health 2017, 17(4S):778. https:\/\/doi.org\/10.1186\/s12889-017-4744-3","1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"Stunted at previous age cohort":{"source":"Odds ratio source: Cousens S, Perin J, Christian P, et al. Modelling stunting in LiST: the effect of applying smoothing to linear growth data. BMC Public Health 2017, 17(4S):778. https:\/\/doi.org\/10.1186\/s12889-017-4744-3","1-6 months":{"OR":45,"Aff":1,"Min":-0.16222222222222216,"Max":0.19333333333333338,"alpha":3.806662,"beta":0.09018049},"6-12 months":{"OR":361.6,"Aff":1,"Min":-0.21432522123893805,"Max":0.27323008849557506,"alpha":5.890539,"beta":0.1232457},"12-23 months":{"OR":174.7,"Aff":1,"Min":-0.2541499713795076,"Max":0.3394390383514597,"alpha":5.16307,"beta":0.1491103},"24-59 months":{"OR":174.7,"Aff":1,"Min":-0.2541499713795076,"Max":0.3394390383514597,"alpha":5.16307,"beta":0.1491103}}},"Impact of complementary feeding on stunting":{"Food secure with promotion and supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"Food secure with neither promotion nor supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1.23,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1.23,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"Food insecure with promotion and supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1.41,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1.41,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"Food insecure with neither promotion nor supplementation":{"source":"Odds ratio source:Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1.69,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1.69,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}}},"Impact of diarrhea on stunting":{"Impact of diarrhea per episode":{"source":"Odds ratio source: Checkley W, Buckley G, Gilman RH, et al. Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol 2008. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18567626","0-1 months":{"OR":1.025,"Aff":1,"Min":-0.01463414634146332,"Max":0.014634146341463537,"alpha":0.02469261,"beta":0.007412432},"1-6 months":{"OR":1.025,"Aff":1,"Min":-0.01463414634146332,"Max":0.014634146341463537,"alpha":0.02469261,"beta":0.007412432},"6-12 months":{"OR":1.025,"Aff":1,"Min":-0.01463414634146332,"Max":0.014634146341463537,"alpha":0.02469261,"beta":0.007412432},"12-23 months":{"OR":1.025,"Aff":1,"Min":-0.01463414634146332,"Max":0.014634146341463537,"alpha":0.02469261,"beta":0.007412432},"24-59 months":{"OR":1.025,"Aff":1,"Min":-0.01463414634146332,"Max":0.014634146341463537,"alpha":0.02469261,"beta":0.007412432}}},"Impact of Zinc supplementation on stunting":{"Zinc supplemented":{"source":"Odds ratio source: Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013; 382(9890): 352-77. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746776 (Supplemental material, page 16.)","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"Not zinc supplemented":{"source":"Odds ratio source: Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013; 382(9890): 352-77. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746776 (Supplemental material, page 16.)","0-1 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"OR":1.11,"Min":-0.06306306306306311,"Max":0.08108108108108095,"alpha":0.10436,"beta":0.03977703},"24-59 months":{"OR":1.11,"Min":-0.06306306306306311,"Max":0.08108108108108095,"alpha":0.10436,"beta":0.03977703}}}},"<Impact Wasting on Mortality>":{"Therapeutic feeding -- severe acute malnutrition recovery rate":{"source":"Recovery rate source: Lenters LM, Wazny K, Webb P, et al. Treatment of severe and moderate acute malnutrition in low- and middle-income settings: A systematic review, meta-analysis and Delphi process. BMC Public Health 2013; 13(Suppl 3): S23. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847503\/. Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013; 382(9890): 352-77. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746776 (Supplemental material, page 15.)","6-12 months":{"Eff":0.78,"Aff":1,"Min":-0.41025641025641024,"Max":0.19230769230769232,"alpha":6.045722,"beta":2.173},"12-23 months":{"Eff":0.78,"Aff":1,"Min":-0.41025641025641024,"Max":0.19230769230769232,"alpha":6.045722,"beta":2.173},"24-59 months":{"Eff":0.78,"Aff":1,"Min":-0.41025641025641024,"Max":0.19230769230769232,"alpha":6.045722,"beta":2.173}},"Treatment of moderate acute malnutrition-- Moderate acute malnutrition recovery rate":{"source":"Recovery rate source: Lenters LM, Wazny K, Webb P, et al. Treatment of severe and moderate acute malnutrition in low- and middle-income settings: A systematic review, meta-analysis and Delphi process. BMC Public Health 2013; 13(Suppl 3): S23. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847503\/. Bhutta ZA, Das JK, Rizvi A, et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet 2013; 382(9890): 352-77. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746776 (Supplemental material, page 15.)","6-12 months":{"Eff":0.84,"Aff":1,"Min":-0.40476190476190477,"Max":0.19047619047619052,"alpha":8.229594,"beta":2.042124},"12-23 months":{"Eff":0.84,"Aff":1,"Min":-0.40476190476190477,"Max":0.19047619047619052,"alpha":8.229594,"beta":2.042124},"24-59 months":{"Eff":0.84,"Aff":1,"Min":-0.40476190476190477,"Max":0.19047619047619052,"alpha":8.229594,"beta":2.042124}},"Impact of complementary feeding on wasting":{"Food secure with promotion and supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":1,"Aff":1,"Min":0,"Max":0}},"Food secure with neither promotion nor supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":1.18,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":1.18,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":1,"Aff":1,"Min":0,"Max":0}},"Food insecure with promotion and supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":1.21,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":1.21,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":1,"Aff":1,"Min":0,"Max":0}},"Food insecure with neither promotion nor supplementation":{"source":"Odds ratio source: Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S.","0-1 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"Eff":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":1.56,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":1.56,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":1,"Aff":1,"Min":0,"Max":0}}}},"<Impact on Anemia>":{"Iron supplementation in pregnancy":{"source":"Efficacy source: Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, et al. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26198451\n\nAffected fraction: % of pregnant women who are iron deficient. Source: Beal T, Massiot E, Arsenault JE, Smith MR, Hijmans RJ. Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes. PLoS One. 2017;12(4):1\u201320. http:\/\/dx.doi.org\/10.1371\/journal.pone.0175554","EFFECT ON PREGNANT WOMEN":{"Eff":0.67,"Min":-0.5373134328358209,"Max":0.253731343283582,"alpha":6.417808,"beta":3.644536}},"Multiple micronutrient supplementation":{"source":"Efficacy source: Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, et al. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26198451\n\nAffected fraction: % of pregnant women who are iron deficient. Source: Beal T, Massiot E, Arsenault JE, Smith MR, Hijmans RJ. Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes. PLoS One. 2017;12(4):1\u201320. http:\/\/dx.doi.org\/10.1371\/journal.pone.0175554","EFFECT ON PREGNANT WOMEN":{"Eff":0.67,"Min":-0.5373134328358209,"Max":0.253731343283582,"alpha":6.417808,"beta":3.644536}},"Iron fortification":{"source":"Efficacy source: Keats EC, Neufeld LM, Garrett GS, Mbuya MNN, Bhutta ZA. Improved micronutrient status and health outcomes in low- and middle-income countries following large-scale fortification: evidence from a systematic review and meta-analysis. Am J Clin Nutr. 2019;109(6):1696-1708. doi:10.1093\/ajcn\/nqz023. https:\/\/pubmed.ncbi.nlm.nih.gov\/30997493\/\n\nAffected fraction: % of women of reproductive age who are iron deficient. Source: Beal T, Massiot E, Arsenault JE, Smith MR, Hijmans RJ. Global trends in dietary micronutrient supplies and estimated prevalence of inadequate intakes. PLoS One. 2017;12(4):1\u201320. http:\/\/dx.doi.org\/10.1371\/journal.pone.0175554","EFFECT ON PREGNANT WOMEN":{"Eff":0.27,"Min":-0.40740740740740744,"Max":0.3333333333333332,"alpha":19.07948,"beta":52.07148},"EFFECT ON NON-PREGNANT WOMEN":{"Eff":0.34,"Min":-0.2941176470588236,"Max":0.23529411764705868,"alpha":35.71785,"beta":69.91045}},"Pregnant women protected via IPTP":{"source":"Efficacy source: Radeva-Petrova D, Kayentao K, Ter Kuile FO, et al. Drugs for preventing malaria in pregnant women in endemic areas: Any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev 2014. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4498495\/\n\nAffected fraction: % of women exposed to falciparum. Source: Guerra CA, Gikandi PW, Tatem AJ, et al. The limits and intensity of Plasmodium falciparum transmission: Implications for malaria control and elimination worldwide. PLoS Medicine 2008; 5(2): e38. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18303939","EFFECT ON PREGNANT WOMEN":{"Eff":0.17,"Min":-0.5882352941176471,"Max":0.5294117647058822,"alpha":7.966562,"beta":39.420361}},"ITN ownership":{"source":"Efficacy source: Radeva-Petrova D, Kayentao K, Ter Kuile FO, et al. Drugs for preventing malaria in pregnant women in endemic areas: Any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev 2014. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4498495\/\n\nAffected fraction: % of women exposed to falciparum. Source: Guerra CA, Gikandi PW, Tatem AJ, et al. The limits and intensity of Plasmodium falciparum transmission: Implications for malaria control and elimination worldwide. PLoS Medicine 2008; 5(2): e38. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18303939","EFFECT ON PREGNANT WOMEN":{"Eff":0,"Aff":0,"Min":0,"Max":0,"alpha":0,"beta":0},"EFFECT ON NON-PREGNANT WOMEN":{"Eff":0.17,"Min":-0.5882352941176471,"Max":0.5294117647058822,"alpha":7.966562,"beta":39.420361}}},"<Reduction in stunting>":{"source":"Efficacy Source: Adair LS, Fall CH, Osmond C, et al. Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies. Lancet. 2013;382(9891):525-534. doi:10.1016\/S0140-6736(13)60103-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/23541370\/","Eff":0.47,"Aff":1,"Min":-0.17021276595744672,"Max":0.19148936170212785},"<Education attainment>":{"source":"Efficacy Source: Fink G, Peet E, Danaei G, et al. Schooling and wage income losses due to early-childhood growth faltering in developing countries: national, regional, and global estimates. Am J Clin Nutr. 2016;104(1):104-112. doi:10.3945\/ajcn.115.123968. https:\/\/pubmed.ncbi.nlm.nih.gov\/27357091\/","Aff":1},"<Relative Risk Anemia>":{"Antepartum hemorrhage":{"mstID":1,"Not anemic":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c90048f4e17b6661a29f6f6\/1552942223259\/Anemia+and+Maternal+Mortality+in+LiST.pdf\n\nAffected fraction: % of women with severe anemia. Source: Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013; 1(1): e16-25.","OR":1,"Aff":1,"Min":0,"Max":0},"Anemic":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c90048f4e17b6661a29f6f6\/1552942223259\/Anemia+and+Maternal+Mortality+in+LiST.pdf\n\nAffected fraction: % of women with severe anemia. Source: Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013; 1(1): e16-25.","OR":10.675,"Min":-0.5686182669789227,"Max":1.6007494145199064,"mean":2.367905,"sd":0.4876618}},"Intrapartum hemorrhage":{"mstID":13,"Not anemic":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c90048f4e17b6661a29f6f6\/1552942223259\/Anemia+and+Maternal+Mortality+in+LiST.pdf\n\nAffected fraction: % of women with severe anemia. Source: Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013; 1(1): e16-25.","OR":1,"Aff":1,"Min":0,"Max":0},"Anemic":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c90048f4e17b6661a29f6f6\/1552942223259\/Anemia+and+Maternal+Mortality+in+LiST.pdf\n\nAffected fraction: % of women with severe anemia. Source: Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013; 1(1): e16-25.","OR":10.675,"Min":-0.5686182669789227,"Max":1.6007494145199064,"mean":2.367905,"sd":0.4876618}},"Postpartum hemorrhage":{"mstID":2,"Not anemic":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c90048f4e17b6661a29f6f6\/1552942223259\/Anemia+and+Maternal+Mortality+in+LiST.pdf\n\nAffected fraction: % of women with severe anemia. Source: Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013; 1(1): e16-25.","OR":1,"Aff":1,"Min":0,"Max":0},"Anemic":{"source":"Odds ratio source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c90048f4e17b6661a29f6f6\/1552942223259\/Anemia+and+Maternal+Mortality+in+LiST.pdf\n\nAffected fraction: % of women with severe anemia. Source: Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Global Health 2013; 1(1): e16-25.","OR":10.675,"Min":-0.5686182669789227,"Max":1.6007494145199064,"mean":2.367905,"sd":0.4876618}}},"<Impact on Diarrhea Incidence>":{"Point-of use filtered water":{"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","0-1 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"1-6 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"6-12 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"12-23 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692},"24-59 months":{"Eff":0.4,"Aff":1,"Min":-0.6,"Max":0.44999999999999984,"alpha":5.829445,"beta":9.227692}},"Piped water":{"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","0-1 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"1-6 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"6-12 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"12-23 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101},"24-59 months":{"Eff":0.23,"Aff":1,"Min":-0.6521739130434783,"Max":0.5652173913043477,"alpha":5.411665,"beta":18.593101}},"Basic sanitation":{"source":"Efficacy source: Wolf J, Hunter PR, Freeman MC, Cummings O, Clasen T, Bartram J, et al. Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta\u2010analysis and meta\u2010regression. Trop Med Int Health. 2018; 23(5): 508-525. doi:10.1111\/tmi.13051","0-1 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"1-6 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"6-12 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"12-23 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978},"24-59 months":{"Eff":0.16,"Aff":1,"Min":-0.875,"Max":0.6875000000000001,"alpha":2.859839,"beta":15.496978}},"Hand washing with soap":{"source":"Efficacy source: Fischer Walker et al., publication forthcoming","0-1 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"1-6 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"6-12 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"12-23 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939},"24-59 months":{"Eff":0.07,"Aff":1,"Min":-0.5714285714285715,"Max":0.5714285714285713,"alpha":8.721878,"beta":116.523939}},"Hygienic disposal of stools":{"source":"Efficacy source: Clasen TF, Bostoen K, Schmidt W-P, Boisson S, Fung ICH, Jenkins MW, et al. Interventions to improve disposal of human excreta for preventing diarrhoea. Cochrane Database of Systematic Reviews 2010;(5):CD007180. doi:10.1002\/14651858.CD007180.pub2","0-1 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"1-6 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":1,"Min":0,"Max":0}},"Zinc for prevention":{"source":"Effectivness source: Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 2011; 11(Suppl 3): S23. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501441. \n\nBlack RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. (Supplemental material, page 18-19.) http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746772\n\nAffected fraction: % of children who are zinc deficient. Source: Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: Results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One 2012; 7(11): e50568.","12-23 months":{"Eff":0.65,"Min":-0.2615384615384616,"Max":0.1692307692307692,"alpha":28.85754,"beta":16.04786},"24-59 months":{"Eff":0.65,"Min":-0.2615384615384616,"Max":0.1692307692307692,"alpha":28.85754,"beta":16.04786}},"Vitamin A for prevention":{"source":"Efficacy source: Imdad A, Yakoob MY, Sudfeld CR, et al. Impact of vitamin A supplementation on infant and childhood mortality. BMC Public Health 2011; 11(Suppl 3): S20. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501438. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. https:\/\/doi.org\/10.1016\/S0140-6736(13)60937-X\n\nAffected fraction: % of children that are vitamin A deficient. Source: Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746772","6-12 months":{"Eff":0.38,"Min":-0.6578947368421053,"Max":0.47368421052631593,"alpha":4.911513,"beta":8.48943},"12-23 months":{"Eff":0.38,"Min":-0.6578947368421053,"Max":0.47368421052631593,"alpha":4.911513,"beta":8.48943},"24-59 months":{"Eff":0.38,"Min":-0.6578947368421053,"Max":0.47368421052631593,"alpha":4.911513,"beta":8.48943}},"Vaccine B":{"1-6 months":{"Eff":0.28,"Aff":0,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105},"6-12 months":{"Eff":0.28,"Aff":0,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105},"12-23 months":{"Eff":0.28,"Aff":0,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105},"24-59 months":{"Eff":0.28,"Aff":0,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105}},"Vaccine C":{"1-6 months":{"Eff":0.28,"Aff":0.055,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105},"6-12 months":{"Eff":0.28,"Aff":0.055,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105},"12-23 months":{"Eff":0.28,"Aff":0.055,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105},"24-59 months":{"Eff":0.28,"Aff":0.055,"Min":-0.16000000000000011,"Max":0.3999999999999999,"alpha":30.33311,"beta":78.56105}}},"<Impact Pneumonia Incidence>":{"Hib vaccine":{"source":"Efficacy source: Griffiths UK, Clark A, Gessner B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta-analysis of controlled clinical trials. Epidemiology and Infection 2012; 140(8): 1343-1355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22583474\n\nAffected fraction: % of pneumonia due to Hib pathogen.","1-6 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.415311,"beta":4.804904},"6-12 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.415311,"beta":4.804904},"12-23 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.415311,"beta":4.804904},"24-59 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.415311,"beta":4.804904}},"Pneumococcal vaccine":{"source":"Efficacy source: Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2009. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19821336\n\nAffected fraction: % of pneumonia due to pneumococcal pathogen.","1-6 months":{"Eff":0.743,"Aff":0.086,"Min":-0.15208613728129206,"Max":0.18438761776581428,"alpha":23.583154,"beta":8.649975},"6-12 months":{"Eff":0.743,"Aff":0.086,"Min":-0.15208613728129206,"Max":0.18438761776581428,"alpha":23.583154,"beta":8.649975},"12-23 months":{"Eff":0.743,"Aff":0.086,"Min":-0.15208613728129206,"Max":0.18438761776581428,"alpha":23.583154,"beta":8.649975},"24-59 months":{"Eff":0.743,"Aff":0.086,"Min":-0.15208613728129206,"Max":0.18438761776581428,"alpha":23.583154,"beta":8.649975}},"Zinc for prevention":{"source":"Effectivness source: Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc supplementation in developing countries: impact on mortality and morbidity due to diarrhea, pneumonia and malaria. BMC Public Health 2011; 11(Suppl 3): S23. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501441. \n\nBlack RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382(9890): 427-51. (Supplemental material, page 18-19.) http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23746772\n\nAffected fraction: % of children who are zinc deficient. Source: Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: Results based on zinc availability in national food supplies and the prevalence of stunting. PLoS One 2012; 7(11): e50568.","12-23 months":{"Eff":0.52,"Min":-0.4615384615384615,"Max":0.30769230769230776,"alpha":10.81625,"beta":10.49013},"24-59 months":{"Eff":0.52,"Min":-0.4615384615384615,"Max":0.30769230769230776,"alpha":10.81625,"beta":10.49013}}},"<Impact Meningitis Incidence>":{"Hib vaccine":{"source":"Efficacy source: Griffiths UK, Clark A, Gessner B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta-analysis of controlled clinical trials. Epidemiology and Infection 2012; 140(8): 1343-1355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22583474\n\nAffected fraction: % of meningitis due to Hib pathogen.","1-6 months":{"Eff":0.94,"Aff":0.14,"Min":-0.11702127659574467,"Max":0.03191489361702131,"alpha":57.415311,"beta":4.804904},"6-12 months":{"Eff":0.94,"Aff":0.14,"Min":-0.11702127659574467,"Max":0.03191489361702131,"alpha":57.415311,"beta":4.804904},"12-23 months":{"Eff":0.94,"Aff":0.14,"Min":-0.11702127659574467,"Max":0.03191489361702131,"alpha":57.415311,"beta":4.804904},"24-59 months":{"Eff":0.94,"Aff":0.14,"Min":-0.11702127659574467,"Max":0.03191489361702131,"alpha":57.415311,"beta":4.804904}},"Pneumococcal vaccine":{"source":"Efficacy source: Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2009. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19821336\n\nAffected fraction: % of pneumonia due to meningitis pathogen.","1-6 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":1,"Min":0,"Max":0}},"Meningococcal A":{"source":"Efficacy source: Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA\u2013TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 2014; 383: 40\u201347. http:\/\/dx.doi.org\/10.1016\/S0140-6736(13)61612-8","1-6 months":{"Eff":0.94,"Min":0,"Max":0},"6-12 months":{"Eff":0.94,"Min":0,"Max":0},"12-23 months":{"Eff":0.94,"Min":0,"Max":0},"24-59 months":{"Eff":0.94,"Min":0,"Max":0}}},"<Breastfeeding Improvement>":{"impact of promotion on breastfeeding - Health system":{"source":"Sinha B, Chowdhury R, Prakash Upadhyay R, Taneja S, Martines J, Bahl R, Jeeva Sankar M; Integrated Interventions Delivered in Health Systems, Home, and Community Have the Highest Impact on Breastfeeding Outcomes in Low- and Middle-Income Countries. Journal Nutr 2017. 147(11S): 2179S\u20132187S, https:\/\/doi.org\/10.3945\/jn.116.242321","0-1 months":{"OR":2.03,"Aff":1,"Min":-0.34482758620689646,"Max":0.5270935960591135,"mean":0.7080358,"sd":0.2160072},"1-6 months":{"OR":3.07,"Aff":1,"Min":-0.3192182410423453,"Max":0.4723127035830618,"mean":1.121678,"sd":0.1973681},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0,"mean":"XX","sd":"XX"},"12-23 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"impact of promotion on breastfeeding - Home\/community":{"source":"Sinha B, Chowdhury R, Prakash Upadhyay R, Taneja S, Martines J, Bahl R, Jeeva Sankar M; Integrated Interventions Delivered in Health Systems, Home, and Community Have the Highest Impact on Breastfeeding Outcomes in Low- and Middle-Income Countries. Journal Nutr 2017. 147(11S): 2179S\u20132187S, https:\/\/doi.org\/10.3945\/jn.116.242321","0-1 months":{"OR":2.17,"Aff":1,"Min":-0.15207373271889393,"Max":0.17972350230414752,"mean":0.7747272,"sd":0.08432813},"1-6 months":{"OR":2.48,"Aff":1,"Min":-0.1975806451612903,"Max":0.24596774193548382,"mean":0.9082586,"sd":0.1122023},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0,"mean":"XX","sd":"XX"},"12-23 months":{"OR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"impact of promotion on breastfeeding - Health system + home\/community":{"source":"Sinha B, Chowdhury R, Prakash Upadhyay R, Taneja S, Martines J, Bahl R, Jeeva Sankar M; Integrated Interventions Delivered in Health Systems, Home, and Community Have the Highest Impact on Breastfeeding Outcomes in Low- and Middle-Income Countries. Journal Nutr 2017. 147(11S): 2179S\u20132187S, https:\/\/doi.org\/10.3945\/jn.116.242321","0-1 months":{"OR":2.33,"Aff":1,"Min":-0.6351931330472104,"Max":1.7682403433476395,"mean":0.8458683,"sd":0.5195054},"1-6 months":{"OR":6.8,"Aff":1,"Min":-0.44852941176470584,"Max":0.8132352941176472,"mean":1.916923,"sd":0.3036345},"6-12 months":{"OR":1.82,"Aff":1,"Min":-0.25274725274725274,"Max":0.3461538461538462,"mean":0.5988365,"sd":0.11516617},"12-23 months":{"OR":1.82,"Aff":1,"Min":-0.25274725274725274,"Max":0.3461538461538462,"mean":0.5988365,"sd":0.11516617},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0}},"impact of promotion on early initiation of breastfeeding - Health system":{"source":"Sinha B, Chowdhury R, Prakash Upadhyay R, Taneja S, Martines J, Bahl R, Jeeva Sankar M; Integrated Interventions Delivered in Health Systems, Home, and Community Have the Highest Impact on Breastfeeding Outcomes in Low- and Middle-Income Countries. Journal Nutr 2017. 147(11S): 2179S\u20132187S, https:\/\/doi.org\/10.3945\/jn.116.242321","0-1 months":{"OR":1.82,"Min":-0.2747252747252747,"Max":0.3736263736263736,"mean":0.5988365,"sd":0.1619694}},"impact of promotion on early initiation of breastfeeding - Home\/community":{"source":"Sinha B, Chowdhury R, Prakash Upadhyay R, Taneja S, Martines J, Bahl R, Jeeva Sankar M; Integrated Interventions Delivered in Health Systems, Home, and Community Have the Highest Impact on Breastfeeding Outcomes in Low- and Middle-Income Countries. Journal Nutr 2017. 147(11S): 2179S\u20132187S, https:\/\/doi.org\/10.3945\/jn.116.242321","0-1 months":{"OR":3.38,"Min":-0.41715976331360943,"Max":0.7159763313609467,"mean":1.217876,"sd":0.2755062}},"impact of promotion on early initiation of breastfeeding - Health system + home\/community":{"source":"Sinha B, Chowdhury R, Prakash Upadhyay R, Taneja S, Martines J, Bahl R, Jeeva Sankar M; Integrated Interventions Delivered in Health Systems, Home, and Community Have the Highest Impact on Breastfeeding Outcomes in Low- and Middle-Income Countries. Journal Nutr 2017. 147(11S): 2179S\u20132187S, https:\/\/doi.org\/10.3945\/jn.116.242321","0-1 months":{"OR":4.96,"Min":-0.41935483870967744,"Max":0.7217741935483869,"mean":1.601406,"sd":0.2772272}},"Kangaroo mother care on breastfeeding":{"source":"Odds ratio source: Boundy EO, Dastjerdi R, Spiegelman D, et al. Kangaroo mother care and neonatal outcomes: A meta-analysis. Pediatrics 2016; 137(1). http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26702029\n\nAffected fraction: % of premature births that survive to day 3 (58%) * % of births that are premature (country-specific).","0-1 months":{"OR":2.33,"Min":-0.4206008583690987,"Max":1.7682403433476395,"mean":0.4054651,"sd":0.08732214},"1-6 months":{"OR":1,"Min":0,"Max":0,"mean":0.3293037,"sd":0.1145844},"6-12 months":{"OR":1,"Aff":1,"Min":0,"Max":0,"mean":"XX","sd":"XX"},"12-23 months":{"OR":1,"Aff":1,"Min":0,"Max":0,"mean":"XX","sd":"XX"},"24-59 months":{"OR":1,"Aff":1,"Min":0,"Max":0,"mean":"XX","sd":"XX"}}},"<Relative Risk Stunting>":{"Diarrhea":{"mstID":8,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1.67,"Aff":1,"Min":-0.281437125748503,"Max":0.3772455089820359,"mean":0.5128236,"sd":0.1686266},"1-6 months":{"RR":1.67,"Aff":1,"Min":-0.281437125748503,"Max":0.3772455089820359,"mean":0.5128236,"sd":0.1686266},"6-12 months":{"RR":1.67,"Aff":1,"Min":-0.281437125748503,"Max":0.3772455089820359,"mean":0.5128236,"sd":0.1686266},"12-23 months":{"RR":1.67,"Aff":1,"Min":-0.281437125748503,"Max":0.3772455089820359,"mean":0.5128236,"sd":0.1686266},"24-59 months":{"RR":1.67,"Aff":1,"Min":-0.281437125748503,"Max":0.3772455089820359,"mean":0.5128236,"sd":0.1686266}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":2.38,"Aff":1,"Min":-0.2857142857142857,"Max":0.3865546218487395,"mean":0.8671005,"sd":0.1716727},"1-6 months":{"RR":2.38,"Aff":1,"Min":-0.2857142857142857,"Max":0.3865546218487395,"mean":0.8671005,"sd":0.1716727},"6-12 months":{"RR":2.38,"Aff":1,"Min":-0.2857142857142857,"Max":0.3865546218487395,"mean":0.8671005,"sd":0.1716727},"12-23 months":{"RR":2.38,"Aff":1,"Min":-0.2857142857142857,"Max":0.3865546218487395,"mean":0.8671005,"sd":0.1716727},"24-59 months":{"RR":2.38,"Aff":1,"Min":-0.2857142857142857,"Max":0.3865546218487395,"mean":0.8671005,"sd":0.1716727}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":6.33,"Aff":1,"Min":-0.2733017377567141,"Max":0.3744075829383885,"mean":1.8453,"sd":0.1628826},"1-6 months":{"RR":6.33,"Aff":1,"Min":-0.2733017377567141,"Max":0.3744075829383885,"mean":1.8453,"sd":0.1628826},"6-12 months":{"RR":6.33,"Aff":1,"Min":-0.2733017377567141,"Max":0.3744075829383885,"mean":1.8453,"sd":0.1628826},"12-23 months":{"RR":6.33,"Aff":1,"Min":-0.2733017377567141,"Max":0.3744075829383885,"mean":1.8453,"sd":0.1628826},"24-59 months":{"RR":6.33,"Aff":1,"Min":-0.2733017377567141,"Max":0.3744075829383885,"mean":1.8453,"sd":0.1628826}}},"Pneumonia":{"mstID":9,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1.55,"Aff":1,"Min":-0.3548387096774194,"Max":0.5483870967741934,"mean":0.4382549,"sd":0.2236036},"1-6 months":{"RR":1.55,"Aff":1,"Min":-0.3548387096774194,"Max":0.5483870967741934,"mean":0.4382549,"sd":0.2236036},"6-12 months":{"RR":1.55,"Aff":1,"Min":-0.3548387096774194,"Max":0.5483870967741934,"mean":0.4382549,"sd":0.2236036},"12-23 months":{"RR":1.55,"Aff":1,"Min":-0.3548387096774194,"Max":0.5483870967741934,"mean":0.4382549,"sd":0.2236036},"24-59 months":{"RR":1.55,"Aff":1,"Min":-0.3548387096774194,"Max":0.5483870967741934,"mean":0.4382549,"sd":0.2236036}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":2.18,"Aff":1,"Min":-0.35779816513761475,"Max":0.5596330275229356,"mean":0.7793249,"sd":0.2259494},"1-6 months":{"RR":2.18,"Aff":1,"Min":-0.35779816513761475,"Max":0.5596330275229356,"mean":0.7793249,"sd":0.2259494},"6-12 months":{"RR":2.18,"Aff":1,"Min":-0.35779816513761475,"Max":0.5596330275229356,"mean":0.7793249,"sd":0.2259494},"12-23 months":{"RR":2.18,"Aff":1,"Min":-0.35779816513761475,"Max":0.5596330275229356,"mean":0.7793249,"sd":0.2259494},"24-59 months":{"RR":2.18,"Aff":1,"Min":-0.35779816513761475,"Max":0.5596330275229356,"mean":0.7793249,"sd":0.2259494}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":6.39,"Aff":1,"Min":-0.34272300469483563,"Max":0.5336463223787169,"mean":1.854734,"sd":0.2141109},"1-6 months":{"RR":6.39,"Aff":1,"Min":-0.34272300469483563,"Max":0.5336463223787169,"mean":1.854734,"sd":0.2141109},"6-12 months":{"RR":6.39,"Aff":1,"Min":-0.34272300469483563,"Max":0.5336463223787169,"mean":1.854734,"sd":0.2141109},"12-23 months":{"RR":6.39,"Aff":1,"Min":-0.34272300469483563,"Max":0.5336463223787169,"mean":1.854734,"sd":0.2141109},"24-59 months":{"RR":6.39,"Aff":1,"Min":-0.34272300469483563,"Max":0.5336463223787169,"mean":1.854734,"sd":0.2141109}}},"Measles":{"mstID":10,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":2.79,"Aff":1,"Min":-0.49820788530465954,"Max":1.0071684587813619,"mean":1.026042,"sd":0.3518276},"1-6 months":{"RR":2.79,"Aff":1,"Min":-0.49820788530465954,"Max":1.0071684587813619,"mean":1.026042,"sd":0.3518276},"6-12 months":{"RR":2.79,"Aff":1,"Min":-0.49820788530465954,"Max":1.0071684587813619,"mean":1.026042,"sd":0.3518276},"12-23 months":{"RR":2.79,"Aff":1,"Min":-0.49820788530465954,"Max":1.0071684587813619,"mean":1.026042,"sd":0.3518276},"24-59 months":{"RR":2.79,"Aff":1,"Min":-0.49820788530465954,"Max":1.0071684587813619,"mean":1.026042,"sd":0.3518276}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":6.01,"Aff":1,"Min":-0.5008319467554077,"Max":0.9966722129783695,"mean":1.793425,"sd":0.3545027},"1-6 months":{"RR":6.01,"Aff":1,"Min":-0.5008319467554077,"Max":0.9966722129783695,"mean":1.793425,"sd":0.3545027},"6-12 months":{"RR":6.01,"Aff":1,"Min":-0.5008319467554077,"Max":0.9966722129783695,"mean":1.793425,"sd":0.3545027},"12-23 months":{"RR":6.01,"Aff":1,"Min":-0.5008319467554077,"Max":0.9966722129783695,"mean":1.793425,"sd":0.3545027},"24-59 months":{"RR":6.01,"Aff":1,"Min":-0.5008319467554077,"Max":0.9966722129783695,"mean":1.793425,"sd":0.3545027}}},"Malaria":{"mstID":11,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Meningitis":{"mstID":15,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":1.86,"Aff":1,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3369232},"1-6 months":{"RR":1.86,"Aff":1,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3369232},"6-12 months":{"RR":1.86,"Aff":1,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3369232},"12-23 months":{"RR":1.86,"Aff":1,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3369232},"24-59 months":{"RR":1.86,"Aff":1,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3369232}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","0-1 months":{"RR":3.01,"Aff":1,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3346581},"1-6 months":{"RR":3.01,"Aff":1,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3346581},"6-12 months":{"RR":3.01,"Aff":1,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3346581},"12-23 months":{"RR":3.01,"Aff":1,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3346581},"24-59 months":{"RR":3.01,"Aff":1,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3346581}}},"Other":{"mstID":13,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","0-1 months":{"RR":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","0-1 months":{"RR":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"},"1-6 months":{"RR":1,"Min":0,"Max":0,"mean":"mean","sd":"sd"},"6-12 months":{"RR":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Min":0,"Max":0}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","0-1 months":{"RR":1.86,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3166265},"1-6 months":{"RR":1.86,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3166265},"6-12 months":{"RR":1.86,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3166265},"12-23 months":{"RR":1.86,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3166265},"24-59 months":{"RR":1.86,"Min":-0.4623655913978495,"Max":0.9354838709677419,"mean":0.6205765,"sd":0.3166265}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","0-1 months":{"RR":3.01,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3224225},"1-6 months":{"RR":3.01,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3224225},"6-12 months":{"RR":3.01,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3224225},"12-23 months":{"RR":3.01,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3224225},"24-59 months":{"RR":3.01,"Min":-0.46843853820598,"Max":0.9269102990033223,"mean":1.10194,"sd":0.3224225}}}},"<Relative Risk Wasting>":{"Diarrhea":{"mstID":8,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1.6,"Aff":1,"Min":-0.25000000000000006,"Max":0.3125,"mean":0.4700036,"sd":0.1467793},"6-12 months":{"RR":1.6,"Aff":1,"Min":-0.25000000000000006,"Max":0.3125,"mean":0.4700036,"sd":0.1467793},"12-23 months":{"RR":1.6,"Aff":1,"Min":-0.25000000000000006,"Max":0.3125,"mean":0.4700036,"sd":0.1467793},"24-59 months":{"RR":1.6,"Aff":1,"Min":-0.25000000000000006,"Max":0.3125,"mean":0.4700036,"sd":0.1467793}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":3.41,"Aff":1,"Min":-0.2668621700879766,"Max":0.348973607038123,"mean":1.226712,"sd":0.1583813},"6-12 months":{"RR":3.41,"Aff":1,"Min":-0.2668621700879766,"Max":0.348973607038123,"mean":1.226712,"sd":0.1583813},"12-23 months":{"RR":3.41,"Aff":1,"Min":-0.2668621700879766,"Max":0.348973607038123,"mean":1.226712,"sd":0.1583813},"24-59 months":{"RR":3.41,"Aff":1,"Min":-0.2668621700879766,"Max":0.348973607038123,"mean":1.226712,"sd":0.1583813}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":12.33,"Aff":1,"Min":-0.253852392538524,"Max":0.34630981346309825,"mean":2.512035,"sd":0.1494067},"6-12 months":{"RR":12.33,"Aff":1,"Min":-0.253852392538524,"Max":0.34630981346309825,"mean":2.512035,"sd":0.1494067},"12-23 months":{"RR":12.33,"Aff":1,"Min":-0.253852392538524,"Max":0.34630981346309825,"mean":2.512035,"sd":0.1494067},"24-59 months":{"RR":12.33,"Aff":1,"Min":-0.253852392538524,"Max":0.34630981346309825,"mean":2.512035,"sd":0.1494067}}},"Pneumonia":{"mstID":9,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1.92,"Aff":1,"Min":-0.32291666666666663,"Max":0.4583333333333333,"mean":0.6523252,"sd":0.1989633},"6-12 months":{"RR":1.92,"Aff":1,"Min":-0.32291666666666663,"Max":0.4583333333333333,"mean":0.6523252,"sd":0.1989633},"12-23 months":{"RR":1.92,"Aff":1,"Min":-0.32291666666666663,"Max":0.4583333333333333,"mean":0.6523252,"sd":0.1989633},"24-59 months":{"RR":1.92,"Aff":1,"Min":-0.32291666666666663,"Max":0.4583333333333333,"mean":0.6523252,"sd":0.1989633}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":4.66,"Aff":1,"Min":-0.33476394849785407,"Max":0.5236051502145922,"mean":1.539015,"sd":0.2079698},"6-12 months":{"RR":4.66,"Aff":1,"Min":-0.33476394849785407,"Max":0.5236051502145922,"mean":1.539015,"sd":0.2079698},"12-23 months":{"RR":4.66,"Aff":1,"Min":-0.33476394849785407,"Max":0.5236051502145922,"mean":1.539015,"sd":0.2079698},"24-59 months":{"RR":4.66,"Aff":1,"Min":-0.33476394849785407,"Max":0.5236051502145922,"mean":1.539015,"sd":0.2079698}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":9.68,"Aff":1,"Min":-0.3698347107438017,"Max":0.5909090909090909,"mean":2.264883,"sd":0.2356029},"6-12 months":{"RR":9.68,"Aff":1,"Min":-0.3698347107438017,"Max":0.5909090909090909,"mean":2.264883,"sd":0.2356029},"12-23 months":{"RR":9.68,"Aff":1,"Min":-0.3698347107438017,"Max":0.5909090909090909,"mean":2.264883,"sd":0.2356029},"24-59 months":{"RR":9.68,"Aff":1,"Min":-0.3698347107438017,"Max":0.5909090909090909,"mean":2.264883,"sd":0.2356029}}},"Measles":{"mstID":10,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":2.58,"Aff":1,"Min":-0.49612403100775193,"Max":0.9767441860465115,"mean":0.9477894,"sd":0.3497131},"6-12 months":{"RR":2.58,"Aff":1,"Min":-0.49612403100775193,"Max":0.9767441860465115,"mean":0.9477894,"sd":0.3497131},"12-23 months":{"RR":2.58,"Aff":1,"Min":-0.49612403100775193,"Max":0.9767441860465115,"mean":0.9477894,"sd":0.3497131},"24-59 months":{"RR":2.58,"Aff":1,"Min":-0.49612403100775193,"Max":0.9767441860465115,"mean":0.9477894,"sd":0.3497131}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":9.63,"Aff":1,"Min":-0.47040498442367606,"Max":0.8691588785046728,"mean":2.264883,"sd":0.3243135},"6-12 months":{"RR":9.63,"Aff":1,"Min":-0.47040498442367606,"Max":0.8691588785046728,"mean":2.264883,"sd":0.3243135},"12-23 months":{"RR":9.63,"Aff":1,"Min":-0.47040498442367606,"Max":0.8691588785046728,"mean":2.264883,"sd":0.3243135},"24-59 months":{"RR":9.63,"Aff":1,"Min":-0.47040498442367606,"Max":0.8691588785046728,"mean":2.264883,"sd":0.3243135}}},"Malaria":{"mstID":11,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Meningitis":{"mstID":15,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":1.65,"Aff":1,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2698234},"6-12 months":{"RR":1.65,"Aff":1,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2698234},"12-23 months":{"RR":1.65,"Aff":1,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2698234},"24-59 months":{"RR":1.65,"Aff":1,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2698234}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":2.73,"Aff":1,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3573772},"6-12 months":{"RR":2.73,"Aff":1,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3573772},"12-23 months":{"RR":2.73,"Aff":1,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3573772},"24-59 months":{"RR":2.73,"Aff":1,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3573772}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/","1-6 months":{"RR":11.21,"Aff":1,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3275064},"6-12 months":{"RR":11.21,"Aff":1,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3275064},"12-23 months":{"RR":11.21,"Aff":1,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3275064},"24-59 months":{"RR":11.21,"Aff":1,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3275064}}},"Other":{"mstID":13,"is greater than 1 standard deviation less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","1-6 months":{"RR":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Min":0,"Max":0}},"between 1 and 2 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","1-6 months":{"RR":1.65,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2555023},"6-12 months":{"RR":1.65,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2555023},"12-23 months":{"RR":1.65,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2555023},"24-59 months":{"RR":1.65,"Min":-0.3939393939393939,"Max":0.6969696969696969,"mean":0.5007753,"sd":0.2555023}},"between 2 and 3 standard deviations less than the median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","1-6 months":{"RR":2.73,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3407355},"6-12 months":{"RR":2.73,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3407355},"12-23 months":{"RR":2.73,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3407355},"24-59 months":{"RR":2.73,"Min":-0.4871794871794872,"Max":1.0146520146520146,"mean":1.004302,"sd":0.3407355}},"more than 3 standard deviations less than median norm":{"source":"Relative risk source: Olofin I, McDonald CM, Ezzati M, et al. Associations of Suboptimal Growth with All-Cause and Cause-Specific Mortality in Children under Five Years: A Pooled Analysis of Ten Prospective Studies. PLOS One 2013; 8(5): e64636. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3667136\/\n\nAffected fraction: % of other mortality due to infectious diseases","1-6 months":{"RR":11.21,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3274825},"6-12 months":{"RR":11.21,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3274825},"12-23 months":{"RR":11.21,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3274825},"24-59 months":{"RR":11.21,"Min":-0.4736842105263158,"Max":0.9000892060660124,"mean":2.416806,"sd":0.3274825}}}},"<Relative Risk Mortality Breastfeeding>":{"Diarrhea":{"mstID":8,"Exclusive breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Predominant breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","1-6 months":{"RR":2.28,"Aff":1,"Min":-0.6271929824561403,"Max":1.6885964912280704,"mean":0.8241754,"sd":0.5029436},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Partial breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","1-6 months":{"RR":4.62,"Aff":1,"Min":-0.6082251082251082,"Max":1.5454545454545454,"mean":1.530395,"sd":0.4771308},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Not breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","1-6 months":{"RR":10.52,"Aff":1,"Min":-0.7347908745247148,"Max":2.7642585551330803,"mean":2.354228,"sd":0.6763443},"6-12 months":{"RR":1.47,"Aff":1,"Min":-0.5442176870748299,"Max":1.2108843537414966,"mean":0.3852624,"sd":0.4047996},"12-23 months":{"RR":2.57,"Aff":1,"Min":-0.5719844357976653,"Max":1.3385214007782102,"mean":0.9439059,"sd":0.4334359},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Pneumonia":{"mstID":9,"Exclusive breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Predominant breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1.66,"Aff":1,"Min":-0.680722891566265,"Max":2.1506024096385548,"mean":0.5068176,"sd":0.5855177},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Partial breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":2.5,"Aff":1,"Min":-0.588,"Max":1.416,"mean":0.9162907,"sd":0.4500661},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Not breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":14.97,"Aff":1,"Min":-0.9552438209752839,"Max":21.227120908483634,"mean":2.706048,"sd":1.582332},"6-12 months":{"RR":1.92,"Aff":1,"Min":-0.5885416666666666,"Max":1.4375,"mean":0.6523252,"sd":0.4545864},"12-23 months":{"RR":1.92,"Aff":1,"Min":-0.5885416666666666,"Max":1.4375,"mean":0.6523252,"sd":0.4545864},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Meningitis":{"mstID":15,"Exclusive breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Predominant breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1.48,"Aff":1,"Min":-0.2297297297297298,"Max":0.29729729729729726,"mean":0.3920421,"sd":0.1327999},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Partial breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":2.84,"Aff":1,"Min":-0.426056338028169,"Max":0.75,"mean":1.043804,"sd":0.2855235},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Not breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":14.4,"Aff":1,"Min":-0.5743055555555556,"Max":1.3513888888888888,"mean":2.667228,"sd":0.4362357},"6-12 months":{"RR":3.69,"Aff":1,"Min":-0.5962059620596206,"Max":1.4850948509485096,"mean":1.305626,"sd":0.4644528},"12-23 months":{"RR":3.69,"Aff":1,"Min":-0.5962059620596206,"Max":1.4850948509485096,"mean":1.305626,"sd":0.4644528},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Measles":{"mstID":10,"Exclusive breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Predominant breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1.48,"Aff":1,"Min":-0.2297297297297298,"Max":0.29729729729729726,"mean":0.3920421,"sd":0.1327999},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Partial breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":2.84,"Aff":1,"Min":-0.426056338028169,"Max":0.75,"mean":1.043804,"sd":0.2855235},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Not breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":14.4,"Aff":1,"Min":-0.5743055555555556,"Max":1.3513888888888888,"mean":2.667228,"sd":0.4362357},"6-12 months":{"RR":3.69,"Aff":1,"Min":-0.5962059620596206,"Max":1.4850948509485096,"mean":1.305626,"sd":0.4644528},"12-23 months":{"RR":3.69,"Aff":1,"Min":-0.5962059620596206,"Max":1.4850948509485096,"mean":1.305626,"sd":0.4644528},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Pertussis":{"mstID":14,"Exclusive breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Predominant breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":1.48,"Aff":1,"Min":-0.2297297297297298,"Max":0.29729729729729726,"mean":0.3920421,"sd":0.1327999},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Partial breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":2.84,"Aff":1,"Min":-0.426056338028169,"Max":0.75,"mean":1.043804,"sd":0.2855235},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Not breastfeeding":{"source":"Relative risk source: Lamberti LM, Zakarija-Grkovic I, Fischer Walker CL, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health 2013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564728","1-6 months":{"RR":14.4,"Aff":1,"Min":-0.5743055555555556,"Max":1.3513888888888888,"mean":2.667228,"sd":0.4362357},"6-12 months":{"RR":3.69,"Aff":1,"Min":-0.5962059620596206,"Max":1.4850948509485096,"mean":1.305626,"sd":0.4644528},"12-23 months":{"RR":3.69,"Aff":1,"Min":-0.5962059620596206,"Max":1.4850948509485096,"mean":1.305626,"sd":0.4644528},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}}},"Neonatal Diarrhea":{"mstID":1,"Exclusive breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Predominant breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Partial breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Not breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"}},"Neonatal Pneumonia":{"mstID":18,"Exclusive breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Predominant breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Partial breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Not breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"}},"Neonatal Sepsis":{"mstID":17,"Exclusive breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Predominant breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Partial breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"},"Not breastfeeding":{"source":"Relative risk source: LiST Technical Note. https:\/\/static1.squarespace.com\/static\/5bbba6574d8711a7dcafa92a\/t\/5c599bf5c830250febc2f326\/1549376501457\/Breastfeeding-effect-sizes-on-mortality.pdf"}}},"<Relative Risk Diarrhea Breastfeeding>":{"Exclusive breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0}},"Predominant breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","0-1 months":{"RR":1.26,"Aff":1,"Min":-0.3571428571428571,"Max":0.5476190476190476,"mean":0.2311117,"sd":0.2228192},"1-6 months":{"RR":1.26,"Aff":1,"Min":-0.3571428571428571,"Max":0.5476190476190476,"mean":0.2311117,"sd":0.2228192},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Partial breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","0-1 months":{"RR":1.68,"Aff":1,"Min":-0.38690476190476186,"Max":0.6428571428571428,"mean":0.5187938,"sd":0.2532888},"1-6 months":{"RR":1.68,"Aff":1,"Min":-0.38690476190476186,"Max":0.6428571428571428,"mean":0.5187938,"sd":0.2532888},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Not breastfeeding":{"source":"Relative risk source: Lamberti LM, Fischer Walker CL, Noiman A, et al. Breastfeeding and the risk for diarrhea morbidity and mortality. BMC Public Health 2011. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21501432","0-1 months":{"RR":2.65,"Aff":1,"Min":-0.35094339622641507,"Max":0.5358490566037738,"mean":0.9745596,"sd":0.2189241},"1-6 months":{"RR":2.65,"Aff":1,"Min":-0.35094339622641507,"Max":0.5358490566037738,"mean":0.9745596,"sd":0.2189241},"6-12 months":{"RR":2.07,"Aff":1,"Min":-0.2801932367149758,"Max":0.39130434782608703,"mean":0.7275486,"sd":0.1684938},"12-23 months":{"RR":2.07,"Aff":1,"Min":-0.2801932367149758,"Max":0.39130434782608703,"mean":0.7275486,"sd":0.1684938},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}}},"<Relative Risk Pneumonia Breastfeeding>":{"Exclusive breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Predominant breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Partial breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Not breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}}},"<Relative Risk Meningitis Breastfeeding>":{"Exclusive breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Predominant breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Partial breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}},"Not breastfeeding":{"0-1 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"1-6 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"6-12 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"12-23 months":{"RR":1,"Aff":1,"Min":0,"Max":0},"24-59 months":{"RR":1,"Aff":1,"Min":0,"Max":0,"mean":"LOGNORMAL"}}},"<Detailed Vaccine Efficacy>":{"DPT Vaccine":{"mstID":33,"Pertussis":{"mstID":14,"Triple":{"source":"Efficacy source: Fulton TR, Phadke VK, Orenstein WA, et al. Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2016; 62(9): 1100-1100. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26908803","1-6 months":{"Eff":0.844,"Aff":1,"Min":-0.04383886255924162,"Max":0.0355450236966825,"alpha":468.9,"beta":89.9},"6-12 months":{"Eff":0.844,"Aff":1,"Min":-0.04383886255924162,"Max":0.0355450236966825,"alpha":468.9,"beta":89.9},"12-23 months":{"Eff":0.844,"Aff":1,"Min":-0.04383886255924162,"Max":0.0355450236966825,"alpha":468.9,"beta":89.9},"24-59 months":{"Eff":0.844,"Aff":1,"Min":-0.04383886255924162,"Max":0.0355450236966825,"alpha":468.9,"beta":89.9}}}},"HIB vaccine":{"mstID":25,"Pneumonia":{"mstID":9,"Single":{"source":"Efficacy source: Griffiths UK, Clark A, Gessner B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta-analysis of controlled clinical trials. Epidemiology and Infection 2012; 140(8): 1343-1355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22583474\n\nAffected fraction: % of pneumonia due to Hib pathogen.","1-6 months":{"Eff":0.59,"Aff":0.14,"Min":-1,"Max":0.45762711864406785,"alpha":1.16,"beta":1.23},"6-12 months":{"Eff":0.59,"Aff":0.14,"Min":-1,"Max":0.45762711864406785,"alpha":1.16,"beta":1.23},"12-23 months":{"Eff":0.59,"Aff":0.14,"Min":-1,"Max":0.45762711864406785,"alpha":1.16,"beta":1.23},"24-59 months":{"Eff":0.59,"Aff":0.14,"Min":-1,"Max":0.45762711864406785,"alpha":1.16,"beta":1.23}},"Double":{"source":"Efficacy source: Griffiths UK, Clark A, Gessner B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta-analysis of controlled clinical trials. Epidemiology and Infection 2012; 140(8): 1343-1355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22583474\n\nAffected fraction: % of pneumonia due to Hib pathogen.","1-6 months":{"Eff":0.92,"Aff":0.14,"Min":-0.2500000000000001,"Max":0.06521739130434775,"alpha":15.9,"beta":1.85},"6-12 months":{"Eff":0.92,"Aff":0.14,"Min":-0.2500000000000001,"Max":0.06521739130434775,"alpha":15.9,"beta":1.85},"12-23 months":{"Eff":0.92,"Aff":0.14,"Min":-0.2500000000000001,"Max":0.06521739130434775,"alpha":15.9,"beta":1.85},"24-59 months":{"Eff":0.92,"Aff":0.14,"Min":-0.2500000000000001,"Max":0.06521739130434775,"alpha":15.9,"beta":1.85}},"Triple":{"source":"Efficacy source: Griffiths UK, Clark A, Gessner B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta-analysis of controlled clinical trials. Epidemiology and Infection 2012; 140(8): 1343-1355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22583474\n\nAffected fraction: % of pneumonia due to Hib pathogen.","1-6 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.57,"beta":4.82},"6-12 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.57,"beta":4.82},"12-23 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.57,"beta":4.82},"24-59 months":{"Eff":0.93,"Aff":0.14,"Min":-0.10752688172043019,"Max":0.043010752688171956,"alpha":57.57,"beta":4.82}},"Booster":{"source":"Efficacy source: Griffiths UK, Clark A, Gessner B, et al. Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: A systematic review and meta-analysis of controlled clinical trials. Epidemiology and Infection 2012; 140(8): 1343-1355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22583474\n\nAffected fraction: % of pneumonia due to Hib pathogen.","1-6 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":1,"Min":0,"Max":0}}},"Meningitis":{"mstID":15,"Single":{"source":"Efficacy source: Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: A systematic review. BMC Public Health 2013; 13(Suppl 3): S21. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847464\/\n\nAffected fraction: % of meningitis due to Hib pathogen.","1-6 months":{"Eff":0.36,"Aff":0.46,"Min":-1,"Max":0.7222222222222223,"alpha":1.29,"beta":2.75},"6-12 months":{"Eff":0.36,"Aff":0.46,"Min":-1,"Max":0.7222222222222223,"alpha":1.29,"beta":2.75},"12-23 months":{"Eff":0.36,"Aff":0.46,"Min":-1,"Max":0.7222222222222223,"alpha":1.29,"beta":2.75},"24-59 months":{"Eff":0.36,"Aff":0.46,"Min":-1,"Max":0.7222222222222223,"alpha":1.29,"beta":2.75}},"Double":{"source":"Efficacy source: Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: A systematic review. BMC Public Health 2013; 13(Suppl 3): S21. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847464\/\n\nAffected fraction: % of meningitis due to Hib pathogen.","1-6 months":{"Eff":0.91,"Aff":0.46,"Min":-0.19780219780219785,"Max":0.06593406593406587,"alpha":24.6,"beta":2.9},"6-12 months":{"Eff":0.91,"Aff":0.46,"Min":-0.19780219780219785,"Max":0.06593406593406587,"alpha":24.6,"beta":2.9},"12-23 months":{"Eff":0.91,"Aff":0.46,"Min":-0.19780219780219785,"Max":0.06593406593406587,"alpha":24.6,"beta":2.9},"24-59 months":{"Eff":0.91,"Aff":0.46,"Min":-0.19780219780219785,"Max":0.06593406593406587,"alpha":24.6,"beta":2.9}},"Triple":{"source":"Efficacy source: Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: A systematic review. BMC Public Health 2013; 13(Suppl 3): S21. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3847464\/\n\nAffected fraction: % of meningitis due to Hib pathogen.","1-6 months":{"Eff":0.94,"Aff":0.14,"Min":-0.17021276595744672,"Max":0.04255319148936174,"alpha":32.469866,"beta":2.554114},"6-12 months":{"Eff":0.94,"Aff":0.14,"Min":-0.17021276595744672,"Max":0.04255319148936174,"alpha":32.469866,"beta":2.554114},"12-23 months":{"Eff":0.94,"Aff":0.14,"Min":-0.17021276595744672,"Max":0.04255319148936174,"alpha":32.469866,"beta":2.554114},"24-59 months":{"Eff":0.94,"Aff":0.14,"Min":-0.17021276595744672,"Max":0.04255319148936174,"alpha":32.469866,"beta":2.554114}},"Booster":{"1-6 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"6-12 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"12-23 months":{"Eff":0,"Aff":1,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":1,"Min":0,"Max":0}}}},"Pneumococcal vaccine":{"mstID":26,"Pneumonia":{"mstID":9,"Triple":{"source":"Efficacy source: Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2009.\n\nAffectiveness source: Rudan I, O\u2019Brien KL, Nair H, et al. Epidemiology and etiology of childhood pneumonia in 2010: Estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. Journal of Global Health 2013; 3(1). http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23826505. (Online supplementary material.)","1-6 months":{"Aff":0.35},"6-12 months":{"Aff":0.35},"12-23 months":{"Aff":0.35},"24-59 months":{"Aff":0.35}}},"Meningitis":{"mstID":15,"Triple":{"source":"Efficacy source: Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2009.\n\nAffected fraction: Davis S, Feikin D, Johnson HL. The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: A systematic review. BMC Public Health 2013; 13(Suppl 3): S21. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24564188.","1-6 months":{"Aff":0.52},"6-12 months":{"Aff":0.52},"12-23 months":{"Aff":0.52},"24-59 months":{"Aff":0.52}}},"Other":{"mstID":13,"Triple":{"source":"Efficacy source: Lucero MG, Dulalia VE, Nillos LT, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 2009.","1-6 months":{"Aff":0.52},"6-12 months":{"Aff":0.52},"12-23 months":{"Aff":0.52},"24-59 months":{"Aff":0.52}}}},"Rotavirus vaccine":{"mstID":45,"Diarrhea":{"mstID":8,"Double":{"source":"Efficacy source: Fisher Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: Quantifying regional variation in effect size. BMC Public Health 2011; 11(Suppl 3): S16.\n\nAffected fraction source: Walker, Christa L. Fischer, et al. \"Global burden of childhood pneumonia and diarrhoea.\"\u00a0The Lancet\u00a0381.9875 (2013): 1405-1416.","1-6 months":{"Aff":0.281},"6-12 months":{"Aff":0.281},"12-23 months":{"Aff":0.281},"24-59 months":{"Aff":0.281}},"Triple":{"source":"Efficacy source: Fisher Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: Quantifying regional variation in effect size. BMC Public Health 2011; 11(Suppl 3): S16.\n\nAffected fraction source: Walker, Christa L. Fischer, et al. \"Global burden of childhood pneumonia and diarrhoea.\"\u00a0The Lancet\u00a0381.9875 (2013): 1405-1416.","1-6 months":{"Eff":0.427,"Aff":0.281,"Min":-0.23419203747072595,"Max":0.2341920374707261,"alpha":37.9,"beta":51.4},"6-12 months":{"Eff":0.427,"Aff":0.281,"Min":-0.23419203747072595,"Max":0.2341920374707261,"alpha":37.9,"beta":51.4},"12-23 months":{"Eff":0.427,"Aff":0.281,"Min":-0.23419203747072595,"Max":0.2341920374707261,"alpha":37.9,"beta":51.4},"24-59 months":{"Eff":0.427,"Aff":0.281,"Min":-0.23419203747072595,"Max":0.2341920374707261,"alpha":37.9,"beta":51.4}},"Booster":{"1-6 months":{"Aff":0.281},"6-12 months":{"Aff":0.281},"12-23 months":{"Aff":0.281},"24-59 months":{"Aff":0.281}}}},"Measles vaccine":{"mstID":21,"Measles":{"mstID":10,"Single":{"source":"Efficacy source: Sudfeld CR, Navar AM, Halsey NA. Efficacy of measles vaccination and vitamin A treatment. International Journal of Epidemiology 2010; 39(Suppl 1): i48-i55. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348126","1-6 months":{"Eff":0.85,"Aff":1,"Min":-0.023529411764705903,"Max":0.023529411764705903,"alpha":1030,"beta":182},"6-12 months":{"Eff":0.85,"Aff":1,"Min":-0.023529411764705903,"Max":0.023529411764705903,"alpha":1030,"beta":182},"12-23 months":{"Eff":0.85,"Aff":1,"Min":-0.023529411764705903,"Max":0.023529411764705903,"alpha":1030,"beta":182},"24-59 months":{"Eff":0.85,"Aff":1,"Min":-0.023529411764705903,"Max":0.023529411764705903,"alpha":1030,"beta":182}},"Double":{"source":"Efficacy source: Sudfeld CR, Navar AM, Halsey NA. Efficacy of measles vaccination and vitamin A treatment. International Journal of Epidemiology 2010; 39(Suppl 1): i48-i55. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348126","1-6 months":{"Eff":0.981,"Aff":1,"Min":0,"Max":0.01936799184505608,"alpha":71.73,"beta":1.86},"6-12 months":{"Eff":0.981,"Aff":1,"Min":0,"Max":0.01936799184505608,"alpha":71.73,"beta":1.86},"12-23 months":{"Eff":0.981,"Aff":1,"Min":0,"Max":0.01936799184505608,"alpha":71.73,"beta":1.86},"24-59 months":{"Eff":0.981,"Aff":1,"Min":0,"Max":0.01936799184505608,"alpha":71.73,"beta":1.86}},"Triple":{"source":"Efficacy source: Sudfeld CR, Navar AM, Halsey NA. Efficacy of measles vaccination and vitamin A treatment. International Journal of Epidemiology 2010; 39(Suppl 1): i48-i55. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348126"},"Booster":{"source":"Efficacy source: Sudfeld CR, Navar AM, Halsey NA. Efficacy of measles vaccination and vitamin A treatment. International Journal of Epidemiology 2010; 39(Suppl 1): i48-i55. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20348126"}}},"Meningococcal vaccine":{"mstID":191,"Meningitis":{"mstID":15,"Single":{"source":"Efficacy source: Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA\u2013TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 2014; 383: 40\u201347. http:\/\/dx.doi.org\/10.1016\/S0140-6736(13)61612-8","1-6 months":{"Eff":0.94,"Min":0,"Max":0},"6-12 months":{"Eff":0.94,"Min":0,"Max":0},"12-23 months":{"Eff":0.94,"Min":0,"Max":0},"24-59 months":{"Eff":0.94,"Min":0,"Max":0}},"Double":{"source":"Efficacy source: Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA\u2013TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 2014; 383: 40\u201347. http:\/\/dx.doi.org\/10.1016\/S0140-6736(13)61612-8","1-6 months":{"Eff":0.94,"Min":0,"Max":0},"6-12 months":{"Eff":0.94,"Min":0,"Max":0},"12-23 months":{"Eff":0.94,"Min":0,"Max":0},"24-59 months":{"Eff":0.94,"Min":0,"Max":0}},"Triple":{"source":"Efficacy source: Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA\u2013TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 2014; 383: 40\u201347. http:\/\/dx.doi.org\/10.1016\/S0140-6736(13)61612-8","1-6 months":{"Eff":0.94,"Min":0,"Max":0},"6-12 months":{"Eff":0.94,"Min":0,"Max":0},"12-23 months":{"Eff":0.94,"Min":0,"Max":0},"24-59 months":{"Eff":0.94,"Min":0,"Max":0}}}},"Vaccine B":{"mstID":192,"Diarrhea":{"mstID":8,"Single":{"1-6 months":{"Eff":0.52,"Aff":0,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0,"Min":-0.4,"Max":0},"12-23 months":{"Eff":0,"Aff":0,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0,"Min":0,"Max":0}},"Double":{"1-6 months":{"Eff":0.52,"Aff":0,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0,"Min":-0.4,"Max":0},"12-23 months":{"Eff":0,"Aff":0,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Eff":0.52,"Aff":0,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0,"Min":-0.4,"Max":0},"12-23 months":{"Eff":0,"Aff":0,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Eff":0.52,"Aff":0,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0,"Min":-0.4,"Max":0},"12-23 months":{"Eff":0,"Aff":0,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0,"Min":0,"Max":0}}},"Pneumonia":{"mstID":9,"Single":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}}},"Meningitis":{"mstID":15,"Single":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}}},"Measles":{"mstID":10,"Single":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}}},"Malaria":{"mstID":11,"Single":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}}},"Pertussis":{"mstID":14,"Single":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}}},"Other":{"mstID":13,"Single":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.12},"6-12 months":{"Aff":0.12},"12-23 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.12,"Min":0,"Max":0}}}},"Vaccine C":{"mstID":193,"Diarrhea":{"mstID":8,"Single":{"1-6 months":{"Eff":0.52,"Aff":0.07,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"12-23 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"24-59 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999}},"Double":{"1-6 months":{"Eff":0.52,"Aff":0.07,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"12-23 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"24-59 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999}},"Triple":{"1-6 months":{"Eff":0.52,"Aff":0.07,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"12-23 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"24-59 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999}},"Booster":{"1-6 months":{"Eff":0.52,"Aff":0.07,"Min":0,"Max":0},"6-12 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"12-23 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999},"24-59 months":{"Eff":0.52,"Aff":0.07,"Min":-0.4,"Max":0.6399999999999999}}},"Pneumonia":{"mstID":9,"Single":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}}},"Meningitis":{"mstID":15,"Single":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}}},"Measles":{"mstID":10,"Single":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}}},"Malaria":{"mstID":11,"Single":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}}},"Pertussis":{"mstID":14,"Single":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}}},"Other":{"mstID":13,"Single":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Double":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Triple":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}},"Booster":{"1-6 months":{"Aff":0.06},"6-12 months":{"Aff":0.06},"12-23 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0},"24-59 months":{"Eff":0,"Aff":0.06,"Min":0,"Max":0}}}},"Malaria vaccine":{"mstID":251,"Malaria":{"mstID":11,"Booster":{"source":"Efficacy source:  RTS,S Clinical Trials Partnership. Supplementary appendix: Efficacy and safety of RTS,S\/AS01 \nmalaria vaccine with or without a booster dose in infants and children in Africa: final results of a \nphase 3, individually randomized, controlled trial. The Lancet. 2015 July 4; 386(9988) 31-45. doi: \n10.1016\/S0140-6736(15)60721-8. PMID: 25913272 PMCID: PMC5626001","1-6 months":{"Eff":0.071,"Aff":1,"Min":-0.5887323943661972,"Max":0.43943661971831},"6-12 months":{"Eff":0.355,"Aff":1,"Min":-0.5887323943661972,"Max":0.43943661971830994},"12-23 months":{"Eff":0.355,"Aff":1,"Min":-0.5887323943661972,"Max":0.43943661971830994},"24-59 months":{"Eff":0.118,"Aff":1,"Min":-0.5916949152542372,"Max":0.4290677966101696}}}}}}